CA2194062C - System for controlling tissue ablation using temperature sensors - Google Patents
System for controlling tissue ablation using temperature sensors Download PDFInfo
- Publication number
- CA2194062C CA2194062C CA002194062A CA2194062A CA2194062C CA 2194062 C CA2194062 C CA 2194062C CA 002194062 A CA002194062 A CA 002194062A CA 2194062 A CA2194062 A CA 2194062A CA 2194062 C CA2194062 C CA 2194062C
- Authority
- CA
- Canada
- Prior art keywords
- temperature
- energy
- energy emitter
- power
- temp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01K—MEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR
- G01K1/00—Details of thermometers not specially adapted for particular types of thermometer
- G01K1/02—Means for indicating or recording specially adapted for thermometers
- G01K1/026—Means for indicating or recording specially adapted for thermometers arrangements for monitoring a plurality of temperatures, e.g. by multiplexing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01K—MEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR
- G01K3/00—Thermometers giving results other than momentary value of temperature
- G01K3/08—Thermometers giving results other than momentary value of temperature giving differences of values; giving differentiated values
- G01K3/14—Thermometers giving results other than momentary value of temperature giving differences of values; giving differentiated values in respect of space
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
- A61B2017/00088—Temperature using thermistors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
- A61B2017/00092—Temperature using thermocouples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00154—Details of operation mode pulsed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00089—Thermal conductivity
- A61B2018/00095—Thermal conductivity high, i.e. heat conducting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00089—Thermal conductivity
- A61B2018/00101—Thermal conductivity low, i.e. thermally insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00107—Coatings on the energy applicator
- A61B2018/00148—Coatings on the energy applicator with metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/0016—Energy applicators arranged in a two- or three dimensional array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/0066—Sensing and controlling the application of energy without feedback, i.e. open loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/0069—Sensing and controlling the application of energy using fuzzy logic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00726—Duty cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00761—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00797—Temperature measured by multiple temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00803—Temperature with temperature prediction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00886—Duration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/128—Generators therefor generating two or more frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
Abstract
This invention is a system and associated method to ablate body tissue using multiple emitters (30) of ablating energy. The system and method convey ablating energy individually to each emitter (30) in a sequence of power pulses.
The system and method periodically sense the temperature of each emitter (30) and compare the sensed temperatures to a desired temperature established for all emitters (30) to generate a signal individually for each emitter (30) based upon the comparison. The system and method individually vary the power pulse to each emitter (30) based upon the signal for that emitter to maintain the temperatures of all emitters essentially at the desired temperature during tissue ablation.
The system and method periodically sense the temperature of each emitter (30) and compare the sensed temperatures to a desired temperature established for all emitters (30) to generate a signal individually for each emitter (30) based upon the comparison. The system and method individually vary the power pulse to each emitter (30) based upon the signal for that emitter to maintain the temperatures of all emitters essentially at the desired temperature during tissue ablation.
Description
219~0~2 SYSTEM FOR CONTROLLING TISSUE ABLATION USING TEMPERATURE SENSORS
Field of the Invention The invention relates to systems and meth-ods for ablating myocardial tissue for the treatment of cardiac conditions.
~ackaround of the xavention l0 Physicians make use of catheters today in medical procedures to gain access into interior regions of the body to ablate targeted tissue areas.
It is important for the physician to be able to pre-cisely locate the catheter and control its emission of energy within the body during tissue ablation procedures.
For example, in electrophysiological therapy, ablation is used to treat cardiac rhythm disturbances.
During these procedures, a physician steers a catheter through a main vein or artery into the interior region of the heart that is to be treated.
The physician places an ablating element carried on the catheter near the cardiac tissue that is to be , ablated. The physician directs energy from the R'O 96100036 PCTIUS94111748 ablating element to ablate the tissue and form a lesion.
In electrophysiological therapy, there is a growing need for ablating elements capable of providing lesions in heart tissue having different geometries.
For example, it is believed the treatment of atrial fibrillation requires the formation of long, thin lesions of different curvilinear shapes in heart tissue. Such long, thin lesion patterns require the deployment within the heart of flexible ablating elements having multiple ablating regions.
The formation of these lesions by ablation may provide the same therapeutic benefits that the complex suture patterns the surgical maze procedure presently provides, but without invasive, open heart surgery.
As another example, it is believed that the treatment of atrial flutter and ventricular 2o tachycardia requires the formation of relatively large and deep lesions patterns in heart tissue.
Merely providing "bigger" electrodes does not meet this need. Catheters carrying large electrodes are difficult to introduce into the heart and difficult to deploy in intimate contact with heart tissue.
However, by distributing the larger ablating mass required for these electrodes among separate, multiple electrodes spaced apart along a flexible body, these difficulties can be overcome.
With larger and/or longer multiple electrode elements comes the demand for more precise control of the ablating process. The delivery of ablating energy must be governed to avoid incidences of tissue damage and coagulum formation. The delivery of ablating energy must also be carefully .. '.77742-7 controlled to assure the formation of uniform and continuous lesions, without hot spots and gaps forming in the ablated tissue.
Sununary of the Invention A principal objective of the invention is to provide improved systems and methods to ablate tissue using multiple ablating elements.
One aspect of the invention provides a system and associated method for ablating body tissue using multiple emitters of ablating energy. The system and method convey ablating energy individually to each emitter in a sequence of power pulses. Each power pulse has a duty cycle (DUTYCYCLE) and an amplitude (AMPLITUDE), which can be expressed either as current or voltage. The power (POWER) delivered to each emitter for ablating tissue is expressed as follows:
POWER ~ AMPLITUDE2 x DUTYCYCLE
The system and method periodically sense temperature at each emitter. The system and method compare the sensed temperatures to a desired temperature established for all emitters to generate a signal individually for each emitter based upon the comparison. The system and method individually vary the power pulse to each emitter based upon the signal generated for that emitter. In this way, the system and method maintain temperatures at all emitters essentially at the desired temperature during tissue ablation.
In one embodiment, the system and method vary the power pulse by individually varying the amplitude of the power pulse based upon the signal for that emitter, while maintaining the duty cycle of the power pulses essentially the same for all R'O 96100036 PCT/US94111748 emitters. In a preferred implementation of this embodiment, the system and method vary amplitude by ~
varying voltage. In a preferred implementation of this embodiment, the duty cycle is set at 1/N, where N is the number of emitters.
In another embodiment, the system and method vary the power pulse by individually varying the duty cycle of the emitter based upon the signal for that emitter, while maintaining the amplitude of the power pulses essentially the same for all emitters.
In another embodiment, the system and method vary the power pulse by individually varying both the duty cycle and the amplitude of the power pulse for each energy emitter based upon the signal for that emitter.
According to another aspect of the invention, a system and method conveying ablating energy to multiple emitters for ablating tissue, while periodically sensing temperature at each emitter. This aspect of the invention selects one of the sensed temperatures based upon preestablished criteria for comparison to a desired temperature to generate a signal. The system and method control the conveyance of ablating energy to all emitters based upon this selected signal.
In a preferred embodiment of this aspect of the invention, the system and method select the highest one of the sensed temperatures.
According to yet another aspect of the invention, the system and method compare the temperature measured at each emitter to the selected temperature to generate a signal individually for each emitter based upon the comparison. The system and method individually control the conveyance of ablating energy to each emitter based upon the ~ signal generated for that emitter.
In a preferred embodiment of this aspect of ~ the invention, the system and method control the conveyance of ablating energy by individually turning off and turning on an energy emitter based upon the signal for that emitter. In this embodiment, the system and method selects for comparison the lowest one of the sensed temperatures.
Another aspect of the invention provides a system and method for ablating body tissue, which periodically sense at least two temperatures at each emitter. The system and method select the hottest one of the selected temperatures and use this selected hottest temperature for comparison with a desired temperature to generate a signal. The system and method control the conveyance of energy to the emitter based upon the signal.
In one variation of this aspect of the invention, the system and method predict the hottest tissue temperature at each emitter based upon the multiple temperatures sensed at that emitter. The system and method use this predicted hottest tissue temperature for comparison with a desired temperature to generate a signal. The system and method control the conveyance of energy to the emitter based upon the signal.
In a preferred embodiment, the system and method convey ablating energy individually to multiple emitters of ablating energy. The system and method periodically sensing at least two temperatures at each emitter. The system and method either select for each emitter the hottest one of the sensed temperatures or derive for each emitter '.77742-7 a prediction of the hottest tissue temperature based upon the sensed temperatures. In this embodiment, the system and method compare either the hottest temperature for each emitter or the predicted hottest tissue temperature for each emitter to a desired temperature established for all emitters to generate a signal individually for each emitter based upon the comparison. The system and method individually control the conveyance of energy to each emitter based upon the signal for that emitter to maintain either the hottest temperature or the predicted hottest tissue temperature at all emitters essentially at the desired temperature during tissue ablation.
More generally, the present invention provides a system for ablating body tissue, comprising: multiple emitters of ablating energy; at least one temperature sensing element at each energy emitter for measuring temperature at the energy emitter, a power controller coupling a source of ablating energy to each energy emitter to convey ablating energy to the energy emitters; a processing element for periodically reading the temperature measured by each temperature sensing element and selecting one of the measured temperatures based upon preestablished criteria for comparison to at least one predetermined temperature to generate a signal; and a temperature controller coupled to the power controller for controlling the conveyance of ablating energy to the energy emitters based upon the signal.
The systems and methods that incorporate the various aspects of the invention, either individually or in combination one with another, are well suited for use for catheter-based cardiac ablation.
.. '.77742-7 - 6a -Other features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended Claims.
Brief Description of the Drawings Fig. 1 is a view of a probe that carries a flexible ablating element having multiple temperature sensing elements;
Fig. 2 is an enlarged view of the handle of the probe shown in Fig. 1, with portions broken away and in section, showing the steering mechanism for flexing the ablating element;
Figs. 3 and 4 show the flexure of the ablating element against different tissue surface contours;
Fig. 5 is an end section view of an ablating electrode element carrying one temperature 2i9406~
sensing element;
~ Fig. 6 is an end section view of an ablating electrode element carrying two temperature ~ sensing elements;
Fig. 7 is an end section view of an ablating electrode element carrying three temperature sensing elements;
Fig. 8 is a side section view of a flexible ablating element comprising multiple rigid electrode elements, showing one manner of mounting at least one temperature sensing element beneath the electrode elements;
Fig. 9 is a side section view of a flexible ablating element comprising multiple rigid electrode elements, showing the mounting of at least one temperature sensing element between adjacent electrode elements;
Fig. 10 is a side section view of a flexible ablating element comprising multiple rigid ablating elements, showing the mounting of at least one temperature sensing element on the electrode elements;
Fig. 11 is an enlarged top view of the mounting the temperature sensing element on the rigid electrode shown in Fig. 10;
Figs. 12A/B/C are schematic views of alternative ways of connecting multiple thermocouples for use in association with an ablating element;
Fig. 13 is a side view of a flexible ablating element with multiple electrodes and multiple thermocouples, and further including an onboard reference thermocouple exposed to the blood pool;
Fig. 14A is an enlarged side section view R'O 96100036 PCTIUS94111748 21940b2 g _ of an onboard reference thermocouple shown in Fig.
13;
Fig. 14B is an enlarged side section view of an alternative embodiment of an onboard reference thermocouple shown in Fig. 13;
Fig. 15A is a side section view of the mounting of a star connection as a reference junction for multiple thermocouples;
Fig. 15B is the schematic representation for the star connection of the reference junction for fig. 15A;
Fig. 16A is a side section view of the mounting of multiple onboard reference thermocouples;
Fig. 16B is a schematic view of the multiple onboard reference thermocouples shown in Fig. 16A;
Fig. 17 is a perspective end view, with portions broken away and in section, of a composite flexible thermocouple usable in association with a flexible ablating element;
Fig. 18 is a side section view of the flexible thermocouple in use in association with a flexible ablating element;
Figs. 19 and 20 are schematic views of a system for controlling the application of ablating energy to multiple electrodes using multiple temperature sensing inputs;
Fig. 21 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using individual amplitude control with collective duty cycle control;
Fig. 22 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using individual duty cycle control with collective amplitude control;
Fig. 23 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using temperature control with hysteresis; and Fig. 24 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using variable amplitude and differential temperature disabling;
Fig. 25 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using differential temperature disabling; and Fig. 26 is a schematic view of a neural network predictor, which receives as input the temperatures sensed by multiple sensing elements at.
a given electrode region and outputs a predicted temperature of the hottest tissue region.
The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodi-ments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
Doscri~tion of the Preferred Embodiments This Specification discloses multiple electrode structures that embody aspects of the invention. This Specification also discloses tissue ablation systems and techniques using multiple temperature sensing elements that embody other aspects of the invention. The illustrated and z ~ 94a~z preferred embodiments discuss these structures, systems, and techniques in the context of catheter-based cardiac ablation. That is because these structures, systems, and techniques are well suited for use in the field of cardiac ablation.
8ti11, it should be appreciated that the invention is applicable for use in other tissue ablation applications. For example, the various aspects of the invention have application in to procedures for ablating tissue in the prostrate, brain, gall bladder, uterus, and other regions of the body, using systems that are not necessarily catheter-based.
I. Flexible Ablating Elements Fig. 1 shows a flexible ablating element 10 for making lesions within the heart.
The element 10 is carried at the distal end of a catheter body 12 of an ablating probe 14. The ablating probe 14 includes a handle 16 at the 2D proximal end of the catheter body 12. The handle 16 and catheter body 12 carry a steering mechanism 18 for selectively bending or flexing the ablating element 10 in two opposite directions, as the arrows in Fig. 1 show.
The steering mechanism 18 can vary. In the illustrated embodiment (see Fig. 2), the steering mechanism 18 includes a rotating cam wheel 20 with an external steering lever 22 (see Fig. 1). As Fig.
2 shows, the cam wheel 20 holds the proximal ends of right and left steering wires 24. The wires 24 pass .
through the catheter body 12 and connect to the left and right sides of a resilient bendable iuire or spring 26 (best shown in Figs. 5,6, and 7) enclosed within a tube 28 inside the ablating element 10.
Further details of this and other types of r .77742-7 steering mechanisms for the ablating element 10 are shown in Lundquist and Thompson U.S. Patent 5,254,088.
As Fig. 1 shows, forward movement of the steering lever 22 flexes or curves the ablating element 10 down.
Rearward movement of the steering lever 22 flexes or curves the ablating element 10 up.
Various access techniques can be used to introduce the probe 14 into the desired region of the heart. For example, to enter the right atrium, the physician can direct the probe 14 through a conventional vascular introduces through the femoral vein. For entry into the left atrium, the physician Can direct the probe 14 through a conventional vascular introduces retrograde through the aortic and mitral valves.
Alternatively, the physician can use the delivery system shown in U.S. Patent No. 5,636,634 which is entitled "Systems and Methods Using Guide Sheaths for Introducing, Deploying, and Stabilizing Cardiac Mapping and Ablation Probes".
The physician can verify intimate contact between the element 10 and heart tissue using conventional pacing and sensing techniques. Once the physician establishes intimate contact with tissue in the desired heart region, the physician applies ablating energy to the element 10.
The type of ablating energy delivered to the element 10 can vary. In the illustrated and preferred embodiment, the element 10 emits electromagnetic radio frequency energy.
The flexible ablating element 10 can be configured in various ways. Figs. 3 and 4 show one 2~9~0~2 R'O 96100036 PCT/fJS94111748 preferred implementation. In this embodiment, the element 10 includes multiple, generally rigid electrode elements 30 arranged in a spaced apart, segmented relationship upon a flexible body 32.
The flexible body 32 is made of a polymeric, electrically nonconductive material, like poly-ethylene or polyurethane. The segmented electrodes 30 comprise solid rings of conductive material, like platinum. The electrode rings 30 are pressure fitted about the body 32. The flexible portions of the body 32 between the rings 30 comprise electrically nonconductive regions. The segmented electrodes 30 are electrically coupled to wires (not shown) to conduct ablating energy to them.
The body 32 can be flexed between the spaced apart electrodes 30 to bring the electrode 30 into intimate contact along a curvilinear surface of the heart wall, whether the heart surface curves outward (as Fig. 3 shows) or curves inward (as Fig. 4 shows). The number of electrode segments 30 and the spacing between them can vary, according to the particular objectives of the ablating procedure.
Likewise, the dimensions of individual electrode segments 30 and underlying body 32 can also vary for the same reason.
Generally speaking, the segmented electrode structure of element 10 is well suited for creating continuous, long and thin lesion patterns, provided that the electrode segments 30 are spaced close enough together and ablating energy is applied simultaneously to adjacent electrode segments 30.
Continuous lesion patterns result when adjacent .
electrode segments are spaced no farther than about 2.5 times the electrode segment diameter apart.
However, ablating energy can be selectively applied 2194pb2 individually to just one or a selected group of electrode segments, when desired, to further vary the size and characteristics of the lesion pattern.
In the segmented electrode structure of element 1D, the diameter of the electrode segments 30 and underlying flexible body 32 can vary from about 4 french to about 10 french. Using rigid electrode segments 30, the minimum diameter is about 1.35 mm.
It has been found that adjacent electrode segments 30 having lengths of less than about 2 mm do not consistently form the desired continuous lesion patterns. Using rigid electrode segments 30, the length of the each electrode segment can vary from about 2 mm to about 10 mm. Using multiple rigid electrode segments longer than about 10 mm each adversely effects the overall flexibility of the element 10(1).
In a representative segmented electrode structure, the flexible body 32 is about 1.35 mm in diameter. The body carries electrode segments 30 each having a length of 3 mm. When eight electrode segments 30 are present and simultaneously activated with 100 Watts of radio frequency energy for about 60 seconds, the lesion pattern is long and thin, measuring about 5 cm in length and about 5 mm in width. The depth of the lesion pattern is about 3 mm, which is more than adequate to create the required transmural lesion (the atrial wall thickness is generally less than 3 mm).
The shape of the lesion pattern created by flexible ablating element 10 can be controlled by flexing the body from straight to curvilinear. As already explained, the body can he remotely steered to flex it into a desired shape, or it can possess a fixed memory, preforming it in a desired shape, 2~~~0~
R'O 96/00036 FCTIUS94/11748 also from straight to curvilinear.
The flexible ablating element 10 can also be used to form larger and deeper lesion patterns by shaping the support body 32 into a circle or a spiral to increase the density of electrodes per given tissue area. This close diagonal spacing and/or close diametric facing of electrode segments in such structures, coupled with the simultaneous emission of ablating energy by the electrode segments 30 significantly concentrates the distribution of ablating energy. The electrode segments 30 provide an additive heating effect that causes lesions to span across electrode segments that are diagonally close and/or diametrically facing. The spanning lesions create large and deep lesion patterns in the tissue region that the element 10 contacts.
In the illustrated and preferred embodiments, the flexible ablating element 10 carries at least two temperature sensing elements 80. The multiple temperature sensing elements 80 measure temperatures along the length of the element 10.
In this configuration, the sensing elements 80 are preferably located in an aligned relationship along one side of each segmented electrode 30, as Figs. 3 and 4 show.
The body 32 preferably carries a fluoroscopic marker (like the stripe 82 shown in Figs. 3 and 4) for orientation purposes. The stripe 82 can be made of a material, like tungsten or barium sulfate, which is extruded into the tubing 12. The extruded stripe can be fully enclosed by the tubing or it can be extruded on the outer diameter of the tubing making it visible to the eye. Fig. 5 shows the marker in the wall of the tubing 12. An alternative embodiment is a fluoro-opaque wire like platinum or gold which can be extruded into the tubing wall. In yet another embodiment, a marker is affixed to the inner diameter of the tubing during manufacturing.
The sensing elements 80 can be on the same side as the fluoroscopic marker 82 (as Figs. 3 and 4 show), or on the opposite side, as long as the physician is aware of the relative position of them.
Aided by the marker 82, the physician orients the element 10(1) so that the temperature sensing elements 80 contact the targeted tissue.
Alternatively, or in combination with the fluoroscopic marker 82, the sensing elements 80 can be consistently located on the inside or outside surface of element 10(1) when flexed in a given direction, up or down. For example, as Fig. 3 shows, when the element 10(1) is flexed downward, the sensing elements 80 are exposed on the inside surface of the element 10(1). As Fig. 4 shows, when the element 10(1) flexed upward, the sensing elements 80 are exposed on the outside surface of the element 10 (1).
Each electrode segment 30 can carry more than a single temperature sensing element 80. As Figs. 5 to 7 show, each electrode segment 30 can carry one, two, three, or more circumferentially spaced apart temperature sensing elements 80. The presence of multiple temperature sensing elements 80 on a single electrode segment 30 gives the physician greater latitude in positioning the ablating element 10, while still providing temperature monitoring.
As Fig. 5 shows, a thin thermally and electrically insulating coating 56 can be applied to the side of the single sensor-segmented electrode 30 opposite to the temperature sensing element 80, WO 96100036 z ~ g ~ a ~ ~ PCT/US94111748 which, in use, is exposed to the blood pool. The coating 56 can be applied, for example, by brushing on a W-type adhesive or by dipping in polytetrafluoroethylene (PTFE) material.
As Fig.6 shows, the mask coating 56 lies between the two sensors 80 on the dual-sensor segmented electrode 30. The mask coating 56 minimizes the connective cooling effects of the blood pool upon the regions of the electrode segment 80 that are exposed to it. The temperature condition sensed by the element 80 facing tissue is thereby more accurate. When more than two temperature sensors 80 are used on a given electrode segment 30, masking becomes less advisable, as it reduces the effective surface of the electrode segment 30 available for tissue contact and ablation.
The temperature sensing elements 80 can comprise thermistors or thermocouples.
The sensing element or elements 80 can be attached on or near the segmented electrodes 30 in various way.
For example, as Fig. 8 shows, each sensing element 80 is sandwiched between the exterior of the flexible body 32 and the underside of the associated rigid electrode segment 30. In the illustrated embodiment, the sensing elements 80 comprise thermistors. The body 32 is flexible enough to fit the sensing element 80 beneath the electrode segment 30. The plastic memory of the body 32 maintains sufficient pressure against the temperature sensing element 80 to establish good thermal conductive contact between it and the electrode segment 30.
In an alternative embodiment (as Fig. 9 shows), the temperature sensing element 80 is located between adjacent electrode segments 30. In this .. '.77742-7 arrangement, each sensing element 80 is threaded through the flexible body 32 between adjacent electrode segments 30. In the illustrated embodiment, the temperature sensing elements 80 comprise thermocouples. When the sensing element 80 comprises a thermocouple, an epoxy material 46, such as *Master Bond Polymer System EP32HT (Master Bond Inc., Hackensack, New Jersey), encapsulates the thermocouple junction 84, securing it to the flexible body 32.
Alternatively, the thermocouple junction 84 can be coated in a thin layer of polytetrafluoroethylene (PTFE) material.
When used in thicknesses of less than about 0.002 inch, these materials have the sufficient insulating properties to electrically insulate the thermocouple junction 84 from the associated electrode segment 30, while providing sufficient thermally conducting properties to establish thermal conductive contact with electrode segment 30. The use of such materials typically will not be necessary when thermistors are used, because conventional thermistors are already encapsulated in an electrically insulating and thermally conducting material.
In another alternative embodiment (as Figs. 10 and 11 show), the temperature sensing element 80 physically projects through an opening 86 in each electrode segment 30.
As in the embodiment shown in Fig. 24, the sensing elements 80 comprise thermocouples, and a thermally conducting and electrically insulating epoxy material encapsulates the thermocouple junction 84, securing it within the opening 86.
It should be appreciated that some sensing elements 80 can be carried by the electrode segments 30, while other sensing elements 80 can be carried *Trade-mark 21~~0~~ .
WO 96!00036 PCT/US94111748 between the element segments 30. Many combinations of sensing element locations are possible, depending upon particular requirements of the ablating procedure.
II. Temperature Sensing Thermocouples For Cardiac Ablation 71. On Soard Reference Thermocouple Each temperature sensing element 80 can comprise a thermistor or a thermocouple. Thermocouples are preferred because, when compared to now-conventional thermistors, a thermocouple is less expensive and presents a smaller, more compact profile. Still, as technology advances, smaller thermistors and other types of miniature temperature sensing elements may become available for use as described in this specification.
Multiple thermocouples can be electrically coupled to sense temperature conditions along an ablating element 10 in various ways. Figs. 12A; 12B
2o and 12C schematically show three representative embodiments.
In the preferred embodiment shown in Fig. 12A, multiple thermocouples (three of which are shown and designated T~ Z 3) are located at or near the ablating electrodes, respectively, E1, E2, and E3.
In conventional fashion, each thermocouple T~z3 includes two electrically insulated wires 34 and 36 of dissimilar metals.
Various types of dissimilar metals can be 3o selected to form the thermocouples T~z3. For example, nickel-10%, chromium can be electrically coupled to either constantan (forming a conventional Type E thermocouple) or nickel-5%(aluminum silicon) (forming a conventional Type K thermocouple); iron can be electrically coupled to constantan (forming 2~~4G~~
a conventional Type J thermocouple); platinum-13%
rhodium can be electrically coupled to platinum (forming a conventional Type R thermocouple);
platinum-10% rhodium can be electrically couple to platinum (forming a conventional Type S
thermocouple); or copper can be electrically coupled to constantan (forming a conventional Type T
thermocouple).
In Fig. 12A, the wires 34 are copper and wires SO 36 are constantan, thereby forming Type T
thermocouples. The wires 34 and 36 are electrically insulated, except for the region 84 where they are stripped of insulation and fused together. This region 84 is located at or near the associated electrode E1/E2/E3. This region 84 is encapsulated in an epoxy or PTFE material, as previously described, to electrically insulate the region 84 from the ablating electrode.
Voltage differences measured between the copper wire 34 and the constantan wire 36 of each thermocouple Ti 2 3 varies with the temperature of the junction region 84. The voltage increases or decreases as the temperature of the region 84, respectively, increases or decreases.
As Fig. 12A also shows, a single reference thermocouple TREE is electrically coupled in common to all three thermocouples T~z3. The reference tlxermocouple TREE is located in a region where a known temperature condition exists. This aspect will be described in greater detail-later.
In Fig. 12A, the reference thermocouple TREF
comprises a length of electrically insulated constantan wire 38, locally stripped of insulation and electrically coupled in parallel to the constantan wires 36 of the three thermocouples T~,2,3.
R'O 96!00036 219 4 Q 6 ~ PCTIUS94111748 The reference thermocouple T~F also includes a length of insulated copper wire 40, locally stripped of insulation and electrically coupled to the constantan wire 38.
The junction region of the constantan wire 38 and the copper wire 40 is the thermocouple junction 42 of the reference thermocouple T~F. This junction 42 is exposed to a known temperature condition. Like the junction regions 84 between the copper and constantan wires 34 and 36 of the other thermocouples Tt,z.3 (i.e., the regions 84), this junction region 42 of the reference thermocouple is also encapsulated in an epoxy or PTFE material that electrically insulates it from the ablating electrodes.
An external processing element 92 is electrically coupled to the thermocouples Tt,t.3 and TREE' The particular details of this connection can vary and will be described in greater detail later.
The processing element 92 registers the magnitudes of the voltage differences existing between the copper wire 40 of T~F and the copper wires 34 of each of the thermocouples T , which t.2.3 are respectively designated oVtZ,3 (in Fig. 12A). The processing element 92 derives from the voltage differences ~Vt,Z,3 the temperature condition at each thermocouple Tt,Z~3, using the following equation:
ovN
TEMP N TEMP~r. -where:
TEMPN is the temperature condition sensed by a selected thermocouple Tw (where N = l, 2 or 3 in Fig. 12A), the magnitude of which is not known.
T~REF is the temperature condition sensed ' . 77742-7 by reference thermocouple TREE, the magnitude of which is known.
~VN is the voltage difference between the copper wire 40 Of TREE and the copper wire 34 of the selected thermocouple TN, which is measured and known.
a is a known function (called the Seebeck coefficient), which expresses the relationship between voltage and temperature for the type of dissimilar metals used in the thermocouple.
Preferably, the processing element 92 includes a memory chip containing a look up table that inputs OVN and relates the expression OVN/a to TEMPN for the particular thermocouple type used. In this way, the processing element 92 directly converts a measured voltage difference OVN to a temperature TEMPN.
Fig. 12B schematically shows an alternative arrangement for electrically coupling three thermocouples Ti,z,3 for use in an ablating element. In Fig. 12B, individual lengths of copper wire 40 are electrically coupled in series with the constantan wires 36 of each thermocouple Tl,z,s, in the same manner described before. The individual junction regions 42 form three individual reference thermocouples TREE 1,2,31 one for each thermocouple Tl,z,3. These junction regions 42 are each individually encapsulated within an epoxy or PTFE material, as already described. The three individual reference thermocouples TREE 1,2,3 are commonly exposed to the same, known temperature condition.
As Fig. 12B shows, the temperature-related 21940~~
R'O 96100036 PCTIUS94/I1748 voltage differences ~V~,z,3 are measured between the copper wire 34 of a selected thermocouple T~,2,3 and the copper wire 40 of its associated reference thermocouple TREE 1,z,3~
Fig. 12C schematically shows another alternative arrangement for electrically coupling three thermocouples T~z3 for use in an ablating element.
In Fig. 12C, a single length of copper wire 40 is electrically coupled in parallel with the constantan wires 36 of each thermocouple T~,z,3. The individual electrical junction regions 42 form three individual reference thermocouples T , one for each REF t,z,3 thermocouple T~z3. As before described, the junction regions 42 are all individually encapsulated within an epoxy or PTFE material. As in the embodiment shown in Fig. 12B, the three individual reference thermocouples TREF i,z,3 are commonly exposed to the same, known temperature condition.
As Fig. 12C shows, the temperature-related voltage differences ~V~z,3 are measured between the copper wire 34 of a selected thermocouple T~z3 and the copper wire 40 of its associated reference thermocouple TREE 1,2,3 Conventional practice would locate the common reference thermocouple TREF in the Fig. 12A
embodiment and the three individual reference thermocouples TREF 1 2, 3 in the Figs. 12B and 12C
embodiments externally within the temperature processing element 92 itself. In these arrangements (which can be employed, if desired), the known temperature condition TEMPREF is the temperature to which the junction regions of the reference thermocouples are exposed. This ambient temperature condition can be measured by a thermistor in the processing element 92. Alternatively, a 21 ~ 4 ~3 ~,~
conventional compensation circuit can be used.
The common reference thermocouple TREE in the Fig. 12A embodiment and the three individual reference thermocouples T~F~,z,3 in the Figs. 12B and 12C can also be carried within the handle 16 of the catheter probe 14. In this arrangement, the known temperature condition TEMPREF is the temperature to which the junction regions 42 of the reference thermocouples are exposed in the handle 16. This temperature condition can be measured by a thermistor in the handle 16 (not shown), or using a conventional compensation circuit. However, in the illustrated and preferred embodiment, the common reference thermocouple TREE in the Fig. 12A
embodiment and the three reference thermocouples TREE
~, z 3 in the Figs. 12B and 12C embodiments are carried onboard the catheter body 12 for exposure to the blood pool in the body. In this preferred arrangement, all reference thermocouples are exposed to blood temperature, either by being located in a heart chamber, or by being located elsewhere in the vascular system of the patient where the catheter body lies. TEMPREF or TEMPREF(l,z,s> thereby is at or near 37°C.
Figs. 13 and 14A show one preferred structural implementation of an onboard reference thermocouple in the arrangement shown schematically in Fig. 12A.
As Fig. 13 shows, a coupler member 94 carried by the catheter body 12 comprises the common reference thermocouple TREE The coupler member 94 is made of a biocompatible, thermally conductive material, like stainless steel or platinum.
As Fig. 13 shows, the coupler member 94 is secured in line onboard the catheter body 12 in a region spaced away from the ablating electrodes E1, E2, and E3. As before described, the coupler member 94 can either be located inside a heart chamber (as Fig. 13 shows), or elsewhere away from the ablating element 10 in the patient s vascular system where the catheter body 12 extends.
If located within the heart chamber itself (as Fig. 13 shows), the coupler member 94 should be spaced far enough away from the electrode elements E1/E2/E3 so that the blood pool contacting the coupler member 94 will not be subject to the localized blood heating effects of the ablation procedure. In this situation, as when the coupler member 94 is more distantly located,outside the heart chamber, the temperature of the blood pool contacting the coupler member 94 will remain essentially constant at about 37° C during the ablation procedure.
As Fig. 14A shows in detail, the coupler member 94 includes an interior bore 96, which is coated with an electrically insulating material 95. A ring 98 is seated in a groove 100 within the bore 96.
The coupler member 94 and ring 98 can comprise a one-piece assembly (as Fig. 14A shows). In this arrangement, the ring 98 includes a split 102 for reducing its diameter, so it can be pressed into and compression-fitted in place within the groove 100.
Alternatively, the coupler member 94 can comprise a two part body, separable along the groove 100, to allow placement of the ring 98. These arrangements allow the electrical connections to the ring 98 to be made outside the member 94, before placement therein.
In the embodiment shown in Fig. 14A, the ring 98 is made of constantan metal. The ring 98 thereby structurally corresponds to the length of constantan wire 38 shown in Fig. 12A, to which the constantan wires 36 of the three thermocouples T~,z3 are electrically coupled in parallel, as Fig. 14A shows.
The length of copper wire 40 (as shown in Fig. 12A) is electrically coupled to the ring 98 (as Fig. 14A
also shows).
This copper wire 40 and the copper wires 34 from each thermocouple T~,Z 3 pass through the bore of the catheter body 12 to the external temperature processing element 92 (via the external connector 104 carried on the handle 16, as Fig. 1 shows. The coupler member 94 and ring 98 thereby serve as an in-line reference thermocouple T~F common to the thermocouples Ti Z, 3' Fig. 14B shows an alternative embodiment for the coupler member 94 that is free of an interior ring 98. In Fig. 14B, the exterior surface of the coupler member 94 is coated with an epoxy or TFE material 106, as previously described. The material 106 bonds the catheter body 12 to the opposite ends of the coupler member 94. The material 106 also electrically insulates the coupler member 94 from the ablating electrodes 30.
The coupler member 94 in Fig. 14B also includes an interior bore 96. The bore 96 has an inner surface region where a layer 108 of constantan material is applied. This layer 108 corresponds to the length of constantan wire 40 shown in Fig. 12A, to which the constantan wires 36 of the three thermocouples T~2,3 are electrically coupled in parallel. The copper wire 40 for the reference thermocouple TREE is also fused to the constantan layer 108.
The constantan ring 98 in Fig. 14A and the constantan layer 108 in Fig. 14B collectively couple 2~9ao~z the constantan wires 34 of each electrode thermocouple T~, 2, 3 to the copper wire 40 of the reference thermocouple TREE. It thereby simplifies electrical connections within the~confined interior regions of-the small diameter of the catheter body 12. The constantan ring 98 and layer 108 also eliminate the need to pass the constantan wires 36 of each electrode thermocouple T~, z, 3 through the entire length of the catheter body 12.
The temperature condition that the onboard reference thermocouple T~F senses is the essentially constant temperature of the blood pool, which the coupler member 94, exposed to the blood pool, thermally conducts. The reference temperature TENHIpREF is thereby not subject to sudden change or variance, as external ambient air temperature can be. Greater accuracy results.
Figs. 15A and 15B show an alternative embodiment for using a single reference thermocouple. The constantan wire 36 from the thermocouples T~,Z,3 are connected together by either a weld or solder connection to the constantan wire 38 in a star configuration (shown in Figs. 15A/B), although other configurations (such as a ladder configuration) can be used. The reference thermocouple TRFF can then be placed under a ring, just like the thermocouples used for temperature sensing. All the thermocouple wires are then wrapped in a tube 114 to thermally and electrically insulate them from the RF wires (not shown). Fig. 15B is the schematic representation of the star connection of Fig 15A.
Figs. 16A and 16B show a preferred structural implementation of multiple onboard reference thermocouples TREE x,2,3 electrically coupled in the arrangement shown schematically in Fig. 12B. As 2194p62 Fig. 16A shows, the three reference thermocouples TftEF 7,2,3 are individually threaded through the catheter body 12 and encapsulated in a electrically insulating and thermally conducting epoxy bubble 110. Preferably, the thermocouples TREE ~,z,3 are spaced closely together.
As Fig. 16B shows, the number of wires entering the processing element 92 is reduced from six to four by electrically coupling the three copper wires 40 associated with the reference thermocouples TREE
within the handle 16 of the probe. This forms a single copper wire 112 common to all the reference thermocouples. The common reference copper wire 112 and the three other copper wires 34 of the theL-mocouples T~,23, are connected to the processing element 92 (as Fig. 16B shows). In this arrangement (as Fig. 16B further shows), ~V~,23 is measured between the individual copper wires 34 for each thermocouple T~23 and the common reference copper wire 112 of the reference thermocouples TREFt,z,a.
The arrangement of multiple onboard reference thermocouples TREY ~,2 3 in the arrangement shown schematically in Fig. 12C can be structurally carried out using a coupler member 94 and ring 98 assembly identical to the one shown in Fig. 14, except that the ring 98 is made of copper metal to correspond to the common copper wire 4O shown Fig.
12C. Alternatively, the multiple onboard reference thermocouples TpEF 1,2,3 in the arrangement shown schematically in Fig. 12C can be structurally implemented using the ring-free coupler member 94 shown in Fig. 15, except that the layer 108 within the coupler bore 96 is made of copper metal to correspond to the common copper wire 40 shown in Fig. 12C.
All of-the thermocouple assemblies described in Figs. 12A, B, and C require an initialization before conducting an ablation procedure. The temperature processing element 92 goes through this initialization phase to compensate for offsets in the voltage differences~V~,Z3 at blood temperature.
Durinq the ablating procedure, the temperature processing element 92 registers the individual change in voltage ~V~,z,3. The temperature processing element 92 applies the associated offset and then converts the resulting change in voltages OV~,Z,3 to temperature readings, using a pre-established look-up table, as already described.
The temperature processing element 92 preferably displays as output the temperature conditions sensed along the ablating element 10. The multiple sensed temperature conditions can also be used in a feedback control loop to control the ablation process itself. This aspect of the invention will be described in greater detail later.
In the preferred embodiment, regardless of the particular type of thermocouple used and the manner in which it is electrically wired within the catheter body 12, the wires 34/36 and 38/40 serving the thermocouples are wrapped in a tube 114 (see Fig. 16A) of thermally insulating material, like polyimide. The tube 114 thermally insulates the thermocouple wires from other wires in the body that carry ablating energy. Thus, the thermocouple wires are thermally insulated Prom heat that may be generated within the catheter body 12 by the transfer of ablating energy to the energy emitting regions at the distal end of the catheter body. The temperature-indicating voltages generated by the thermocouples are thereby not altered by exposure of 2194~6,~
R'O 96/00036 PCTIUS94/11748 the thermocouple wires to this source of heat within the catheter body.
B. Lov Profile composite Thermocouple Fig. 17 shows a composite, low profile thermocouple 116 that can be used in association with all types of flexible ablating elements 10.
The thermocouple 116 comprises a thin, semi-flexible substrate ll8.formed of an electrically insulating material, like polyimide. In the illustrated embodiment, the substrate 118 is tubular in shape.
Of course, other shapes could be used.
Two electrical conductive pathways 120 and 122 extend along the surface of the substrate 118. The pathways 120 and 122 can be applied by conventional sputter coating techniques or an ion beam assisted deposition (IBAD) process. Alternatively, small gauge wires of these different metal materials could be embedded within the tubular substrate during its extrusion or molding.
Each pathway 120 and 122 comprises a different electrically conductive metal material. Preferably, one pathway 120 is formed by applying copper, and the other pathway 122 is formed by applying constantan.
The ends of the two pathways 120 and 122 are electrically fused together on the substrate 118.
In the illustrated and preferred embodiment, a band 124 of metal material of one of the pathways 120 and 122 spans the ends of the pathways 120 and 122, electrically fusing them together. This band 124 forms a thermocouple junction on the surface of the substrate 118. Small gauge wires 126 and 128 of matching metal material are electrically coupled to the opposite ends of the pathways 120 and 122.
A thin, outer electrically insulating layer 130 is applied over the pathways 120 and 122 and thermocouple band 124 to complete the assembly of the low profile thermocouple 116.
Additional pathways 120/122, bands 124, and wires 126/128 can be applied to a single substrate 118 to form multiple thermocouple junctions on it.
As Fig. 18 shows, the semi-flexible thermocouple 116 can be made small enough in diameter to fit within the structure l0 beneath or near an ablating element 30. Alternatively, the thermocouple 116 can be made large enough in diameter to fit over the flexible body 32, as Fig. 18 also shows.
III. Control of Cardiac Ablation Bsing Multiple Temperature Feedback Control Fig. 19 shows, in schematic form, a system 200 for applying ablating energy by multiple emitters based, at least in part, upon local temperature conditions sensed by multiple sensing elements 80.
In Fig. 19, the multiple sensing elements 80 2o comprise thermocouples 208, 209, and 210 individually associated with the multiple emitters of ablating energy, which comprise electrode regions 201, 202, and 203. The system 200 also includes a common reference thermocouple 211 carried within the coupler element 211 for exposure to the blood pool, as previously described. Alternatively, other kinds of temperature sensing elements can be used, like, for example, thermistors, fluoroptic sensors, and resistive temperature sensors, in which case the 3o reference sensor 211 would typically not be required.
The system 200 further includes an indifferent electrode 219 for operation in a uni-polar mode.
The ablating energy emitters 201, 202, 203 can comprise the rigid electrode segments 3o previously R'O 96100036 PCT/US94111748 described. Alternatively, the electrode regions 201, 202, 203 can comprise a continuous or segmented flexible electrode of wrapped wire or ribbon. It should be appreciated that the system 200 can be used in association with any ablating element that employs multiple, independently actuated ablating elements.
The system 200 includes a source 217 of ablating energy. In Fig. 19, the source 217 generates radio frequency (RF) energy. The source 217 is connected (through a conventional isolated output stage 216) to an array of power switches 214, one for each electrode region 201, 202, and 203. A connector 212 (carried by the probe handle) electrically couples each electrode region 201, 203, 203 to its own power switch 214 and to other parts of the system 200.
The system 200 also includes a microcontroller 231 coupled via an interface 230 to each power switch 214. The microcontroller 231 turns a given power switch 214 on or off to deliver RF power from the source 217 individually to the electrode regions 201, 202, and 203. The delivered RF energy flows from the respective electrode region 201, 202, and 203, through tissue, to the indifferent electrode 219, which is connected to the return path of the isolated output stage 216. .
The power switch 214 and interface 230 configuration can vary according to the type of ablating energy being applied. Fig. 20 shows a representative implementation for applying RF
ablating energy.
In this implementation, each power switch 214 includes an N-MOS power transistor 235 and a P-MOS
power transistor 236 coupled in between the respective electrode region 201, 202, and 203 and zl~~o~z R'O 96/00036 PCTlUS94111748 the isolated output stage 216 of the power source a17.
A. diode 233 conveys the positive phase of RF
ablating energy to the electrode region. A diode 234 conveys the negative phase of the RF ablating energy to the electrode region. Resistors 237 and 238 bias the N-MOS and P-MOS power transistors 235 and 236 in conventional fashion.
The interface 230 for each power switch 214 includes two NPN transistors 239 and 240. The emitter of the NPN transistor 239 is coupled to the gate of the N-MOS power transistor 235. The collector of the NPN transistor 240 is coupled to the gate of the P-MOS power transistor 280.
The interface for each power switch 214 also includes a control bus 243 coupled to the microcontroller 231. The control bus 243 connects each power switch 214 to digital ground (DGND) of the microcontroller 231. The control bus 243 a lso includes a (+) power line (+5V) connected to the collector of the NPN transistor 239 and a (-) power line (-5V) connected to the emitter of the NPN
interface transistor 240.
The control bus 243 for each power switch 214 further includes an EgE~ line. The base of the NPN
transistor 239 is coupled to the ESE~ line of the control bus 243. The base of the NPN transistor 240 is also coupled the E~~ line of the control bus 243 via the Zener diode 241 and a resistor 232. ESE~
line connects to the cathode of the Zener diode 241 through the resistor 232. The Zener diode 241 is selected so that the NPN transistor 240 turns on when Esc exceeds about 3 volts (which, for the particular embodiment shown, is logic 1).
It should be appreciated that the interface 230 z ~ q4a6z can be designed to handle other logic level standards. In the particular embodiment, it is designed to handle conventional TTL (transistor transfer logic) levels.
The microcontroller 231 sets EsE~ of the control bus 243 either at logic 1 or at logic 0. At logic 1, the gate of the N-MOS transistor 235 is connected to (+) 5 volt line through the NPN transistors 239.
Similarly, the gate of the P-MOS transistor 236 is connected to the (-) 5 volt line through the NPN
transistor 240. This conditions the power transistors 235 and 236 to conduct RF voltage from the source 217 to the associated electrode region.
The power switch 214 is "on."
When the microcontroller 231 sets ESE~ at logic 0, no current flows through the NPN transistors 239 and 240. This conditions the power transistors 235 and 236 to block the conduction of RF voltage to the associated electrode region. The power switch 214 i8 ~Off."
The system 200 (see Fig. 19) further includes two analog multiplexers (MUX) 224 and 225. The multiplexers 224 and 225 receive voltage input from each thermocouple 208, 209, 210, and 211. The microcontroller 231 controls both multiplexers 224 and 225 to select voltage inputs from the multiple temperature sensing thermocouples 208, 209, 210, and 211.
The voltage inputs from the thermocouples 208, 209, 210, and 211 are sent to front end signal conditioning electronics. The inputs are amplified by differential amplifier 226, which reads the voltage differences between the copper wires of the thermocouples 208/209/210 and the reference thermocouple 211. The voltage differences are 219~Q~~
W~ 96/00036 PCTIU894111748 conditioned by element 227 and converted to digital codes by the analog-to-digital converter 228. The look-up table 229 converts the digital codes to temperature codes. The temperature codes are read by the microcontroller 231.
The microcontroller 231 compares the temperature codes for each thermocouple 208, 209, and 210 to preselected criteria to generate feedback signals.
The preselected criteria are inputted through a user interface 232. These feedback signals control the interface power switches 214 via the interface 230, turning the electrodes 201, 202, and 203 off and on.
The other multiplexer 225 connects the thermocouples 208, 209, 210, and 211 selected by the microcontroller 231 to a temperature controller 215.
The temperature controller 215 also includes front end signal conditioning electronics, as already described with reference to elements 226, 227, 228, and 229. These electronics convert the voltage differences between the copper wires of the thermocouples 208/209/210 and the reference thermocouple 211 to temperature codes. The temperature codes are read by the controller and compared to preselected criteria to generate feedback signals. These feedback signals control the amplitude of the voltage (or current) generated by the source 217 for delivery to the electrodes 201, 202, and 203.
Based upon the feedback signals of the microcontroller 231 and the temperature controller 215, the system 200 distributes power to the multiple electrode regions 201, 202, and 203.to establish and maintain a uniform distribution of temperatures along the ablating element. In this way, the system 200 obtains safe and efficacious .. . 77742-7 lesion formation using multiple emitters of ablating energy.
The system 200 can control the delivery of ablating energy in different ways. Several representative modes will now be described.
Individual Amplitudes/Collective Duty Cycle The electrode regions 201, 202, and 203 will be symbolically designated E(J), where J represents a given electrode region (J=1 to N).
As before described, each electrode region E(J) has at least one temperature sensing element 208, 209, and 210, which will be designated S(J,K), where J represents the electrode region and K represents the number of temperature sensing elements on each electrode region (K=1 to M).
In this mode (see Fig. 21), the microcontroller 316 operates the power switch interface 230 to deliver RF power from the source 217 in multiple pulses of duty cycle 1/N.
With pulsed power delivery, the amount of power PE(J) conveyed to each individual electrode region E(J) is expressed as follows:
2 0 PE cJ> ~ AMPS cJ~ 2 x DUTYCYCLEE ~J) where:
AMPEtJ> is the amplitude of the RF voltage conveyed to the electrode region E(J), and ~. 77742-7 - 35a -DUTYCYCLEE~J) is the duty cycle of the pulse, expressed as follows:
DUTYCYCLE _ TONES,) ') TONE~~) +TOFFE~~) where:
R'O 96/00036 PCT/US94111748 TONE~~~ is the time that the electrode region E(J) emits energy during each pulse period, TOFFE~~~ is the time that the electrode region E(J) does not emit energy during each pulse period.
The expression TONE~~~ + TOFFE~~~ represents the period of the pulse for each electrode region E(J).
In this mode, the microcontroller 231 collectively establishes duty cycle (DUTYCYCLF~~~~) of 1/N for each electrode region (N being equal to the number of electrode regions).
The microcontroller 231 may sequence successive power pulses to adjacent electrode regions so that the end of the duty cycle for the preceding pulse overlaps slightly with the beginning of the duty cycle for the next pulse. This overlap in pulse duty cycles assures that the source 217 applies power continuously, with no periods of interruption caused by open circuits during pulse switching between successive electrode regions.
2o In this mode, the temperature controller 215 makes.individual adjustments to the amplitude of the RF voltage for each electrode region (AMPE~~~) , thereby individually changing the power PE~~~ of ablating energy conveyed during the duty cycle to each electrode region, as controlled by the microcontroller 231.
In this mode, the microcontroller 231 cycles in successive data acquisition sample periods. During each sample period, the microcontroller 231 selects individual sensors S(J,R), and voltage differences are read by the controller 215 (through MITX 225) and converted to temperature codes TEN~(J).
When there is more than one sensing element associated with a given electrode region, the controller 215 registers all sensed temperatures for the given electrode region and selects among these the highest sensed temperature, which constitutes T1~(J). The temperature sensing element providing the highest sensed temperature for a given electrode region is the one in most intimate contact with heart tissue. The lower sensed temperatures of the ottner sensing elements on the given electrode region indicate that the other sensing elements are not in such intimate contact, and are instead exposed to connective cooling in the blood pool.
In this mode, the controller 215 compares the temperature TE~(J) locally sensed at each electrode E(J) during each data acquisition period to a setpoint temperature TEMPgEr established by the physician. Based upon this comparison, the controller 215 varies the amplitude AMPE~~~ of the RF
voltage delivered to the electrode region E(J), while the microcontroller 231 maintains the DUTYCYCLF~~~~ for that electrode region and all other electrode regions, to establish and maintain TEMP(J) at the setpoint temperature TEMPSET.
The set point temperature TEMPser can vary according to the judgment of the physician and empirical data. A representative set point temperature for cardiac ablation is believed to lie in the range of 40°C to 95° C, with 70° C being a representative preferred value.
The manner in which the controller 215 governs AMPE~~~ can incorporate proportional control methods, proportional integral derivative (PID) control methods, or fuzzy logic control methods.
For example, using proportional control methods, if the temperature sensed by the first sensing element TEMP(1) > TEMPser , the control signal generated by the controller 215 individually reduces 21~~J~2 R'O 96100036 PCTIUS94111748 the amplitude AMPE~» of the RF voltage applied to the first electrode region E(1), while the microcontroller 231 keeps the collective duty cycle DUTYCYCLEE~» for the first electrode region E(1) the same. If the temperature sensed by the second sensing element TEMP(2) < TEI4P5~ , the control signal of the controller 215 increases the amplitude AMPE~z~ of the pulse applied to the second electrode region E(2), while the microcontroller 231 keeps the collective duty cycle DUTYCYCLEE~z~ for the second electrode region E(2) the same as DUTYCYCLEE~», and so on. If the temperature sensed by a given sensing element is at the set point temperature TEMPsEr, no change in RF voltage amplitude is made for the associated electrode region.
The controller 215 continuously processes voltage difference inputs during successive data acquisition periods to individually adjust AMPE~~~ at each electrode region E(J), while the microcontroller 231 keeps the collective duty cycle the same for all electrode regions E(J). In this way, the mode maintains a desired uniformity of temperature along the length of the ablating element.
Using a proportional integral differential (PID) control technique, the controller 215 takes into account not only instantaneous changes that occur in a given sample period, but also changes that have occurred in previous sample periods and the rate at which these changes are varying over time. Thus, using a PID control technique, the controller 215 will respond differently to a given proportionally large instantaneous difference between TEMP (J) and TEMPgET, depending upon whether the difference is getting larger or smaller, compared to previous 2p940b~
instantaneous differences, and whether the rate at which the difference is changing since previous sample periods is increasing or decreasing.
Collective Amps;tuda/Tnd~v;dua~ Dutv Cvclaa In this feedback mode (see Fig. 22), the controller 215 governs the source 217 to collectively control the RF voltage amplitude AMPE~~~
for all electrode regions based upon the lowest local temperature sensed TEMPSHIN. At the same time, in this feedback mode, the microcontroller 231 individually alters the power conveyed to the electrode regions where temperatures greater than TEMP~~N are sensed, by adjusting the duty cycle DUTYCYCLEE~~~ of these electrode regions.
In this mode, as in the previous mode, the microcontroller 231 separates the power into multiple pulses. Initially, each pulse has the same duty cycle (DUTYCYCLEE~~~) of 1/N. As in the previous mode, the application of successive RF pulses to adjacent electrode regions may be timed to overlap so that the source 318 applies power continuously to the electrode regions E(J).
The controller 215 circles in successive data acquisition periods to sequentially read the temperature sensed by each sensing element TEMP(J).
When there are multiple sensing elements associated with each electrode region, the controller 215 registers all sensed temperatures for the particular electrode and selects among these the highest sensed temperature, which is TEMP(J).
In this mode, the controller 215 compares, during each data acquisition period, the individual temperatures sensed TEMP(J) to the set point temperature TEMP~Er. The controller 215 also selects R'O 96/00036 PCT/US94111748 the lowest sensed temperature TEMPsHIN. The controller-215 adjusts AMPE~~~ to maintain TEMP~IN =
TEMPSEr, using proportional, PID, or fuzzy logic control techniques. At the same time, the microcontroller 231 adjusts DUTYCYCLEE~~~ of the electrode regions where TEMP(J) > TEMPawIN to maintain TEMP (J) = TEMP ser' For example, using only proportional control techniques, if TEMPsHIN < TEMPsEr~ the controller 215 collectively increases the amplitude of the RF
voltage of all electrode regions, based upon the difference between TEMPsMIN and TEMPSET (~TEMPSHIN/SEr) ~
until TEMPsNtN > TEMPsET.
During this time (when TEMPsNIN remains below TEMPsEr), the microcontroller 231 also controls the application of power to the other electrode regions E(J) where the local sensed temperature TEMP(J) is above TEMPsNIN, as follows:
(i) if TEMP(J) < TEMPser , the microcontroller 231 increases the duty cycle of the power applied to the electrode region E(J) at the RF voltage amplitude established by ~T~SNIN/SET' (ii) if TEMP(J) > TEMPser , the microcontroller 231 decreases the duty cycle of the power applied to the electrode region E(J) at the RF voltage amplitude established by ~T~sNIN/sEr' (iii) if TEMPs~NI = TEMPsET , the microcontroller 231 maintains the duty cycle for the given electrode region E(N) at the RF voltage amplitude established by ~TI~SMIN/SEr' When TEMPsHIN > TEMPsEr, the controller 215 collectively reduces the RF voltage amplitude delivered to all electrode regions. When TEI~~IN =
2~9~o~z WO 96/00036 PCT/US9411f748 TEMPsfT, the controller 215 collectively maintains the then-established RF voltage amplitude delivered to all electrode regions.
T_emoerat~e Control with Hysterp~i.
In this mode (see Fig. 23), as in the previous modes, the system 200 cycles in successive data acquisition periods to sequentially register the temperature sensed by the sensing elements TEMP(J) for the electrode regions E(J). As before, when there are multiple sensing elements associated with each electrode region, the system 200 registers all sensed temperatures for the particular electrode region and selects among these the highest sensed temperature, which becomes TEMP(J).
In this mode, the microcontroller 231 compares the temperature sensed locally at each electrode region TENIP(J) during each data acquisition period to high and low threshold temperatures TEMPHireRese and 2O T'~P~~HRESH~ where T~ az~trsx'T~PSZ~,.INCR
where T~ ioo-mmrsx'T~sEx,-INCR
T~SET is the set point temperature, and INCR is a preselected increment.
When operated in this mode, the microcontroller 231 operates the power switch interface 230 to turn a given electrode region E(J) off when the local temperature sensed at that electrode region TEMP(J) z TEMPNITHRESN~ The microcontroller 231 keeps the electrode region turned off until the locally sensed temperature TEMP (J) drops below TEMPi~HRESH' The microcontroller 231 turns a given electrode region 2 ~ q4a~~
R'O 96/00036 PCTlUS94111748 E(J) on and supplies power at a selected voltage amplitude when the local temperature sensed at that electrode region TEMP (J) < TEMPi~HRESH~
The values for TEMPT and INCR can vary according to the judgment of the physician and empirical data.
As before stated, a representative value for TEMPsEr is believed to lie in the range of 40°C and 95°C, with a preferred value of 70°C. A representative value of INCR is believed to lie in the range of 2°C
to 8°C, with a preferred representative value of around 5°C.
In this implementation, the controller 215 establishes a constant RF voltage amplitude sufficiently high to maintain the desired temperature conditions during hysteresis.
Alternatively, the controller 215 can have the capability to adjust voltage should the coolest sensed temperature TEMP~~N decrease below a selected lower limit below TEMP~~HRESH ~ or should the longest duty cycle exceed a predetermined value. It should be appreciated that there are other ways of adjusting and maintaining the amplitude while the hysteresis control method is carried out.
Diftereatial Temperature Disablinc In this mode (see Fig. 24), the temperature controller 215 selects at the end of each data acquisition phase the sensed temperature that is the greatest for that phase (TEMP). The temperature controller 215 also selects for that phase the sensed temperature that is the lowest (TEMP~Iw).
The controller 215 compares the selected hottest sensed temperature TEMPS to a selected high set point temperature TEMPH». The comparison generates a control signal that collectively adjusts the 2~~4Q~.~
R'O 96f00036 PCTIU594111748 amplitude of the RF voltage for all electrodes using proportional, PID, or fuzzy logic control techniques.
In a proportion control implementation scheme:
(i) If TEMPS > TEMPHiser , the control signal collectively decreases the amplitude of the RF voltage delivered to all electrode regions;
(ii) If TEMPs~x < TEMPNISET . the control signal collectively increases the amplitude of the RF voltage delivered to all electrode regions:
(iii) If TEIHP~ = TEMPNtseT . no change in the amplitude of the RF voltage delivered to all electrode regions is made.
It should be appreciated that the temperature controller 215 can select for amplitude control purposes any one of the sensed temperatures TEMP, TEMP~tN, or temperatures in between, and compare this temperature condition to a preselected temperature condition.
Working in tandem with the amplitude control function of the temperature controller 215, the microcontroller 231 governs the delivery of power to the electrode regions based upon difference between a given local temperature TEMP (J) and TEMP~tN. This implementation computes the difference between local sensed temperature TEMP(J) and TEMP~IN and compares this difference to a selected set point temperature difference pTEMP~T. The comparison generates a control signal that governs the delivery of power to the electrode regions.
If the local sensed temperature TEMP(J) for a given electrode region E(J) exceeds the lowest R'O 96100036 PCT/US94111748 sensed temperature TEMP~~N by as much as or more than ATEMPSEr (that is, if TEMP (J) - TEMP~IN x ATEMPSEr), the microcontroller 231 turns the given electrode region E(J) off. The microcontroller 231 turns the given electrode E(J) back on when TEMP(J) - TEMP~IN
~T~SET' Alternatively (see Fig. 25), instead of comparing TEMP(J) and TEMP~~N, the microcontroller 231 can compare TEMPS and TEMPyx~N. When the l0 difference between TEMPS and TEMP~~N equals or exceeds a - predetermined amount ~TEMPSEr, the controller 231 turns all electrode regions off, except the electrode region where TEMP~~N exists.
The controller 231 turns these electrode regions back on when the temperature difference between TEMPS and TEMP~Iw is less than ATEMPser' Some of the above-described temperature-based control schemes alter power by adjusting the amplitude of the RF voltage. It should be appreciated that, alternatively, power can be altered by the adjusting the amplitude of RF
current. Therefore, the quantity AMPE~~~ used in this Specification can mean either RF voltage amplitude or RF current amplitude.
III. Selecting Among Multiple Temperature sensing Elements As previously described, a given electrode region can have more than one temperature sensing element associated with it. In the previously descibed ablation control modes, the controller 215 registers all sensed temperatures for the given electrode region and selects among these the highest sensed temperature, which constitutes TEMP(J).
There are alternative ways of making this selection.
vincr PradictedKottea Because of the heat exchange between the tissue and the electrode region, the temperature sensing elements may not measure exactly the maximum temperature at the region. This is because the region of hottest temperature occurs beneath the surface of the tissue at a depth of about 0.5 to 2.0 mm from where the energy emitting electrode region (and the associated sensing element) contacts the tissue. If the power is applied to heat the tissue too quickly, the actual maximum tissue temperature in this subsurface region may exceed 100° C and lead to tissue desiccation.
Fig. 26 shows an implementation of a neural network predictor 300, which receives as input the temperatures sensed by multiple sensing elements S(J,K) at each electrode region, where J represents a given electrode region (J = 1 to N) and K
represents the number of temperature sensing 2o elements on each electrode region (K = 1 to M). The predictor 300 outputs a predicted temperature of the hottest tissue region T~PRE~(t). The controller 215 and microcontroller 231 derive the amplitude and duty cycle control signals based upon T~PRED(t)~ in the same manners already described using T1~(J).
The predictor. 300 uses a two-layer neural network, although more hidden layers could be used.
As shown in Fig. 26, the predictor 300 includes a first and second hidden layers and four neurons, designated N~~,X~, where 1, identifies the layer 1 or 2 and X identifies a neuron on that layer. The first layer (Iri) has three neurons (X = 1 to 3), as follows N~~ »; N~~ Z~; and N~~ 3~. The second layer (L=2) comprising one output neuron (X=1), designated N~2 ~~.
~~.77742-7 Temperature readings from the multiple sensing elements, only two of which - TS1(n) and TS2(n) - are shown for purposes of illustration, are weighed and inputted to each neuron N(1,1); N(1,2); and N(1,3) of the first layer.
Fig. 26 represents the weights as WL(x,N), where L=1; k is the input sensor order; and N is the input neuron number 1, 2, or 3 of the first layer.
The output neuron N(2,1) of the second layer receives as inputs the weighted outputs of the neurons N(1,1);
N(1,2); and N(1,3). Fig. 26 represents the output weights as WL(o,x). where L=2; O is the output neuron 1, 2, or 3 of the first layer; and X is the input neuron number of the second layer. Based upon these weighted inputs, the output neuron N(2,1) predicts T~pRED(t) The predictor 300 must be trained on a known set of data containing the temperature of the sensing elements TS1 and TS2 and the temperature of the hottest region, which have been previously acquired experimentally. For example, using a back-propagation model, the predictor 300 can be trained to predict the known hottest temperature of the data set with the least mean square error. Once the training phase is completed, the predictor 300 can be used to predict T~pRED(t) -Other types of data processing techniques can be used to derive TMpxpgEDct) . See, e.g. , US Patent No. 5, 906, 614, which is entitled "Tissue Heating and Ablation Systems and Methods Using Predicted Temperature for Monitoring and Control".
The illustrated and preferred embodiments use digital processing controlled by a computer to analyze information and generate feedback signals.
219~Ob2 It should be appreciated that other logic control circuits using micro-switches, AND/OR gates, inverters, anolog circuits, and the like are equivalent to the micro-processor controlled techniques shown in the preferred embodiments.
Various features of the invention are set forth in the following claims.
r
Field of the Invention The invention relates to systems and meth-ods for ablating myocardial tissue for the treatment of cardiac conditions.
~ackaround of the xavention l0 Physicians make use of catheters today in medical procedures to gain access into interior regions of the body to ablate targeted tissue areas.
It is important for the physician to be able to pre-cisely locate the catheter and control its emission of energy within the body during tissue ablation procedures.
For example, in electrophysiological therapy, ablation is used to treat cardiac rhythm disturbances.
During these procedures, a physician steers a catheter through a main vein or artery into the interior region of the heart that is to be treated.
The physician places an ablating element carried on the catheter near the cardiac tissue that is to be , ablated. The physician directs energy from the R'O 96100036 PCTIUS94111748 ablating element to ablate the tissue and form a lesion.
In electrophysiological therapy, there is a growing need for ablating elements capable of providing lesions in heart tissue having different geometries.
For example, it is believed the treatment of atrial fibrillation requires the formation of long, thin lesions of different curvilinear shapes in heart tissue. Such long, thin lesion patterns require the deployment within the heart of flexible ablating elements having multiple ablating regions.
The formation of these lesions by ablation may provide the same therapeutic benefits that the complex suture patterns the surgical maze procedure presently provides, but without invasive, open heart surgery.
As another example, it is believed that the treatment of atrial flutter and ventricular 2o tachycardia requires the formation of relatively large and deep lesions patterns in heart tissue.
Merely providing "bigger" electrodes does not meet this need. Catheters carrying large electrodes are difficult to introduce into the heart and difficult to deploy in intimate contact with heart tissue.
However, by distributing the larger ablating mass required for these electrodes among separate, multiple electrodes spaced apart along a flexible body, these difficulties can be overcome.
With larger and/or longer multiple electrode elements comes the demand for more precise control of the ablating process. The delivery of ablating energy must be governed to avoid incidences of tissue damage and coagulum formation. The delivery of ablating energy must also be carefully .. '.77742-7 controlled to assure the formation of uniform and continuous lesions, without hot spots and gaps forming in the ablated tissue.
Sununary of the Invention A principal objective of the invention is to provide improved systems and methods to ablate tissue using multiple ablating elements.
One aspect of the invention provides a system and associated method for ablating body tissue using multiple emitters of ablating energy. The system and method convey ablating energy individually to each emitter in a sequence of power pulses. Each power pulse has a duty cycle (DUTYCYCLE) and an amplitude (AMPLITUDE), which can be expressed either as current or voltage. The power (POWER) delivered to each emitter for ablating tissue is expressed as follows:
POWER ~ AMPLITUDE2 x DUTYCYCLE
The system and method periodically sense temperature at each emitter. The system and method compare the sensed temperatures to a desired temperature established for all emitters to generate a signal individually for each emitter based upon the comparison. The system and method individually vary the power pulse to each emitter based upon the signal generated for that emitter. In this way, the system and method maintain temperatures at all emitters essentially at the desired temperature during tissue ablation.
In one embodiment, the system and method vary the power pulse by individually varying the amplitude of the power pulse based upon the signal for that emitter, while maintaining the duty cycle of the power pulses essentially the same for all R'O 96100036 PCT/US94111748 emitters. In a preferred implementation of this embodiment, the system and method vary amplitude by ~
varying voltage. In a preferred implementation of this embodiment, the duty cycle is set at 1/N, where N is the number of emitters.
In another embodiment, the system and method vary the power pulse by individually varying the duty cycle of the emitter based upon the signal for that emitter, while maintaining the amplitude of the power pulses essentially the same for all emitters.
In another embodiment, the system and method vary the power pulse by individually varying both the duty cycle and the amplitude of the power pulse for each energy emitter based upon the signal for that emitter.
According to another aspect of the invention, a system and method conveying ablating energy to multiple emitters for ablating tissue, while periodically sensing temperature at each emitter. This aspect of the invention selects one of the sensed temperatures based upon preestablished criteria for comparison to a desired temperature to generate a signal. The system and method control the conveyance of ablating energy to all emitters based upon this selected signal.
In a preferred embodiment of this aspect of the invention, the system and method select the highest one of the sensed temperatures.
According to yet another aspect of the invention, the system and method compare the temperature measured at each emitter to the selected temperature to generate a signal individually for each emitter based upon the comparison. The system and method individually control the conveyance of ablating energy to each emitter based upon the ~ signal generated for that emitter.
In a preferred embodiment of this aspect of ~ the invention, the system and method control the conveyance of ablating energy by individually turning off and turning on an energy emitter based upon the signal for that emitter. In this embodiment, the system and method selects for comparison the lowest one of the sensed temperatures.
Another aspect of the invention provides a system and method for ablating body tissue, which periodically sense at least two temperatures at each emitter. The system and method select the hottest one of the selected temperatures and use this selected hottest temperature for comparison with a desired temperature to generate a signal. The system and method control the conveyance of energy to the emitter based upon the signal.
In one variation of this aspect of the invention, the system and method predict the hottest tissue temperature at each emitter based upon the multiple temperatures sensed at that emitter. The system and method use this predicted hottest tissue temperature for comparison with a desired temperature to generate a signal. The system and method control the conveyance of energy to the emitter based upon the signal.
In a preferred embodiment, the system and method convey ablating energy individually to multiple emitters of ablating energy. The system and method periodically sensing at least two temperatures at each emitter. The system and method either select for each emitter the hottest one of the sensed temperatures or derive for each emitter '.77742-7 a prediction of the hottest tissue temperature based upon the sensed temperatures. In this embodiment, the system and method compare either the hottest temperature for each emitter or the predicted hottest tissue temperature for each emitter to a desired temperature established for all emitters to generate a signal individually for each emitter based upon the comparison. The system and method individually control the conveyance of energy to each emitter based upon the signal for that emitter to maintain either the hottest temperature or the predicted hottest tissue temperature at all emitters essentially at the desired temperature during tissue ablation.
More generally, the present invention provides a system for ablating body tissue, comprising: multiple emitters of ablating energy; at least one temperature sensing element at each energy emitter for measuring temperature at the energy emitter, a power controller coupling a source of ablating energy to each energy emitter to convey ablating energy to the energy emitters; a processing element for periodically reading the temperature measured by each temperature sensing element and selecting one of the measured temperatures based upon preestablished criteria for comparison to at least one predetermined temperature to generate a signal; and a temperature controller coupled to the power controller for controlling the conveyance of ablating energy to the energy emitters based upon the signal.
The systems and methods that incorporate the various aspects of the invention, either individually or in combination one with another, are well suited for use for catheter-based cardiac ablation.
.. '.77742-7 - 6a -Other features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended Claims.
Brief Description of the Drawings Fig. 1 is a view of a probe that carries a flexible ablating element having multiple temperature sensing elements;
Fig. 2 is an enlarged view of the handle of the probe shown in Fig. 1, with portions broken away and in section, showing the steering mechanism for flexing the ablating element;
Figs. 3 and 4 show the flexure of the ablating element against different tissue surface contours;
Fig. 5 is an end section view of an ablating electrode element carrying one temperature 2i9406~
sensing element;
~ Fig. 6 is an end section view of an ablating electrode element carrying two temperature ~ sensing elements;
Fig. 7 is an end section view of an ablating electrode element carrying three temperature sensing elements;
Fig. 8 is a side section view of a flexible ablating element comprising multiple rigid electrode elements, showing one manner of mounting at least one temperature sensing element beneath the electrode elements;
Fig. 9 is a side section view of a flexible ablating element comprising multiple rigid electrode elements, showing the mounting of at least one temperature sensing element between adjacent electrode elements;
Fig. 10 is a side section view of a flexible ablating element comprising multiple rigid ablating elements, showing the mounting of at least one temperature sensing element on the electrode elements;
Fig. 11 is an enlarged top view of the mounting the temperature sensing element on the rigid electrode shown in Fig. 10;
Figs. 12A/B/C are schematic views of alternative ways of connecting multiple thermocouples for use in association with an ablating element;
Fig. 13 is a side view of a flexible ablating element with multiple electrodes and multiple thermocouples, and further including an onboard reference thermocouple exposed to the blood pool;
Fig. 14A is an enlarged side section view R'O 96100036 PCTIUS94111748 21940b2 g _ of an onboard reference thermocouple shown in Fig.
13;
Fig. 14B is an enlarged side section view of an alternative embodiment of an onboard reference thermocouple shown in Fig. 13;
Fig. 15A is a side section view of the mounting of a star connection as a reference junction for multiple thermocouples;
Fig. 15B is the schematic representation for the star connection of the reference junction for fig. 15A;
Fig. 16A is a side section view of the mounting of multiple onboard reference thermocouples;
Fig. 16B is a schematic view of the multiple onboard reference thermocouples shown in Fig. 16A;
Fig. 17 is a perspective end view, with portions broken away and in section, of a composite flexible thermocouple usable in association with a flexible ablating element;
Fig. 18 is a side section view of the flexible thermocouple in use in association with a flexible ablating element;
Figs. 19 and 20 are schematic views of a system for controlling the application of ablating energy to multiple electrodes using multiple temperature sensing inputs;
Fig. 21 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using individual amplitude control with collective duty cycle control;
Fig. 22 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using individual duty cycle control with collective amplitude control;
Fig. 23 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using temperature control with hysteresis; and Fig. 24 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using variable amplitude and differential temperature disabling;
Fig. 25 is a schematic flow chart showing an implementation of the temperature feedback controller shown in Figs. 19 and 20, using differential temperature disabling; and Fig. 26 is a schematic view of a neural network predictor, which receives as input the temperatures sensed by multiple sensing elements at.
a given electrode region and outputs a predicted temperature of the hottest tissue region.
The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodi-ments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
Doscri~tion of the Preferred Embodiments This Specification discloses multiple electrode structures that embody aspects of the invention. This Specification also discloses tissue ablation systems and techniques using multiple temperature sensing elements that embody other aspects of the invention. The illustrated and z ~ 94a~z preferred embodiments discuss these structures, systems, and techniques in the context of catheter-based cardiac ablation. That is because these structures, systems, and techniques are well suited for use in the field of cardiac ablation.
8ti11, it should be appreciated that the invention is applicable for use in other tissue ablation applications. For example, the various aspects of the invention have application in to procedures for ablating tissue in the prostrate, brain, gall bladder, uterus, and other regions of the body, using systems that are not necessarily catheter-based.
I. Flexible Ablating Elements Fig. 1 shows a flexible ablating element 10 for making lesions within the heart.
The element 10 is carried at the distal end of a catheter body 12 of an ablating probe 14. The ablating probe 14 includes a handle 16 at the 2D proximal end of the catheter body 12. The handle 16 and catheter body 12 carry a steering mechanism 18 for selectively bending or flexing the ablating element 10 in two opposite directions, as the arrows in Fig. 1 show.
The steering mechanism 18 can vary. In the illustrated embodiment (see Fig. 2), the steering mechanism 18 includes a rotating cam wheel 20 with an external steering lever 22 (see Fig. 1). As Fig.
2 shows, the cam wheel 20 holds the proximal ends of right and left steering wires 24. The wires 24 pass .
through the catheter body 12 and connect to the left and right sides of a resilient bendable iuire or spring 26 (best shown in Figs. 5,6, and 7) enclosed within a tube 28 inside the ablating element 10.
Further details of this and other types of r .77742-7 steering mechanisms for the ablating element 10 are shown in Lundquist and Thompson U.S. Patent 5,254,088.
As Fig. 1 shows, forward movement of the steering lever 22 flexes or curves the ablating element 10 down.
Rearward movement of the steering lever 22 flexes or curves the ablating element 10 up.
Various access techniques can be used to introduce the probe 14 into the desired region of the heart. For example, to enter the right atrium, the physician can direct the probe 14 through a conventional vascular introduces through the femoral vein. For entry into the left atrium, the physician Can direct the probe 14 through a conventional vascular introduces retrograde through the aortic and mitral valves.
Alternatively, the physician can use the delivery system shown in U.S. Patent No. 5,636,634 which is entitled "Systems and Methods Using Guide Sheaths for Introducing, Deploying, and Stabilizing Cardiac Mapping and Ablation Probes".
The physician can verify intimate contact between the element 10 and heart tissue using conventional pacing and sensing techniques. Once the physician establishes intimate contact with tissue in the desired heart region, the physician applies ablating energy to the element 10.
The type of ablating energy delivered to the element 10 can vary. In the illustrated and preferred embodiment, the element 10 emits electromagnetic radio frequency energy.
The flexible ablating element 10 can be configured in various ways. Figs. 3 and 4 show one 2~9~0~2 R'O 96100036 PCT/fJS94111748 preferred implementation. In this embodiment, the element 10 includes multiple, generally rigid electrode elements 30 arranged in a spaced apart, segmented relationship upon a flexible body 32.
The flexible body 32 is made of a polymeric, electrically nonconductive material, like poly-ethylene or polyurethane. The segmented electrodes 30 comprise solid rings of conductive material, like platinum. The electrode rings 30 are pressure fitted about the body 32. The flexible portions of the body 32 between the rings 30 comprise electrically nonconductive regions. The segmented electrodes 30 are electrically coupled to wires (not shown) to conduct ablating energy to them.
The body 32 can be flexed between the spaced apart electrodes 30 to bring the electrode 30 into intimate contact along a curvilinear surface of the heart wall, whether the heart surface curves outward (as Fig. 3 shows) or curves inward (as Fig. 4 shows). The number of electrode segments 30 and the spacing between them can vary, according to the particular objectives of the ablating procedure.
Likewise, the dimensions of individual electrode segments 30 and underlying body 32 can also vary for the same reason.
Generally speaking, the segmented electrode structure of element 10 is well suited for creating continuous, long and thin lesion patterns, provided that the electrode segments 30 are spaced close enough together and ablating energy is applied simultaneously to adjacent electrode segments 30.
Continuous lesion patterns result when adjacent .
electrode segments are spaced no farther than about 2.5 times the electrode segment diameter apart.
However, ablating energy can be selectively applied 2194pb2 individually to just one or a selected group of electrode segments, when desired, to further vary the size and characteristics of the lesion pattern.
In the segmented electrode structure of element 1D, the diameter of the electrode segments 30 and underlying flexible body 32 can vary from about 4 french to about 10 french. Using rigid electrode segments 30, the minimum diameter is about 1.35 mm.
It has been found that adjacent electrode segments 30 having lengths of less than about 2 mm do not consistently form the desired continuous lesion patterns. Using rigid electrode segments 30, the length of the each electrode segment can vary from about 2 mm to about 10 mm. Using multiple rigid electrode segments longer than about 10 mm each adversely effects the overall flexibility of the element 10(1).
In a representative segmented electrode structure, the flexible body 32 is about 1.35 mm in diameter. The body carries electrode segments 30 each having a length of 3 mm. When eight electrode segments 30 are present and simultaneously activated with 100 Watts of radio frequency energy for about 60 seconds, the lesion pattern is long and thin, measuring about 5 cm in length and about 5 mm in width. The depth of the lesion pattern is about 3 mm, which is more than adequate to create the required transmural lesion (the atrial wall thickness is generally less than 3 mm).
The shape of the lesion pattern created by flexible ablating element 10 can be controlled by flexing the body from straight to curvilinear. As already explained, the body can he remotely steered to flex it into a desired shape, or it can possess a fixed memory, preforming it in a desired shape, 2~~~0~
R'O 96/00036 FCTIUS94/11748 also from straight to curvilinear.
The flexible ablating element 10 can also be used to form larger and deeper lesion patterns by shaping the support body 32 into a circle or a spiral to increase the density of electrodes per given tissue area. This close diagonal spacing and/or close diametric facing of electrode segments in such structures, coupled with the simultaneous emission of ablating energy by the electrode segments 30 significantly concentrates the distribution of ablating energy. The electrode segments 30 provide an additive heating effect that causes lesions to span across electrode segments that are diagonally close and/or diametrically facing. The spanning lesions create large and deep lesion patterns in the tissue region that the element 10 contacts.
In the illustrated and preferred embodiments, the flexible ablating element 10 carries at least two temperature sensing elements 80. The multiple temperature sensing elements 80 measure temperatures along the length of the element 10.
In this configuration, the sensing elements 80 are preferably located in an aligned relationship along one side of each segmented electrode 30, as Figs. 3 and 4 show.
The body 32 preferably carries a fluoroscopic marker (like the stripe 82 shown in Figs. 3 and 4) for orientation purposes. The stripe 82 can be made of a material, like tungsten or barium sulfate, which is extruded into the tubing 12. The extruded stripe can be fully enclosed by the tubing or it can be extruded on the outer diameter of the tubing making it visible to the eye. Fig. 5 shows the marker in the wall of the tubing 12. An alternative embodiment is a fluoro-opaque wire like platinum or gold which can be extruded into the tubing wall. In yet another embodiment, a marker is affixed to the inner diameter of the tubing during manufacturing.
The sensing elements 80 can be on the same side as the fluoroscopic marker 82 (as Figs. 3 and 4 show), or on the opposite side, as long as the physician is aware of the relative position of them.
Aided by the marker 82, the physician orients the element 10(1) so that the temperature sensing elements 80 contact the targeted tissue.
Alternatively, or in combination with the fluoroscopic marker 82, the sensing elements 80 can be consistently located on the inside or outside surface of element 10(1) when flexed in a given direction, up or down. For example, as Fig. 3 shows, when the element 10(1) is flexed downward, the sensing elements 80 are exposed on the inside surface of the element 10(1). As Fig. 4 shows, when the element 10(1) flexed upward, the sensing elements 80 are exposed on the outside surface of the element 10 (1).
Each electrode segment 30 can carry more than a single temperature sensing element 80. As Figs. 5 to 7 show, each electrode segment 30 can carry one, two, three, or more circumferentially spaced apart temperature sensing elements 80. The presence of multiple temperature sensing elements 80 on a single electrode segment 30 gives the physician greater latitude in positioning the ablating element 10, while still providing temperature monitoring.
As Fig. 5 shows, a thin thermally and electrically insulating coating 56 can be applied to the side of the single sensor-segmented electrode 30 opposite to the temperature sensing element 80, WO 96100036 z ~ g ~ a ~ ~ PCT/US94111748 which, in use, is exposed to the blood pool. The coating 56 can be applied, for example, by brushing on a W-type adhesive or by dipping in polytetrafluoroethylene (PTFE) material.
As Fig.6 shows, the mask coating 56 lies between the two sensors 80 on the dual-sensor segmented electrode 30. The mask coating 56 minimizes the connective cooling effects of the blood pool upon the regions of the electrode segment 80 that are exposed to it. The temperature condition sensed by the element 80 facing tissue is thereby more accurate. When more than two temperature sensors 80 are used on a given electrode segment 30, masking becomes less advisable, as it reduces the effective surface of the electrode segment 30 available for tissue contact and ablation.
The temperature sensing elements 80 can comprise thermistors or thermocouples.
The sensing element or elements 80 can be attached on or near the segmented electrodes 30 in various way.
For example, as Fig. 8 shows, each sensing element 80 is sandwiched between the exterior of the flexible body 32 and the underside of the associated rigid electrode segment 30. In the illustrated embodiment, the sensing elements 80 comprise thermistors. The body 32 is flexible enough to fit the sensing element 80 beneath the electrode segment 30. The plastic memory of the body 32 maintains sufficient pressure against the temperature sensing element 80 to establish good thermal conductive contact between it and the electrode segment 30.
In an alternative embodiment (as Fig. 9 shows), the temperature sensing element 80 is located between adjacent electrode segments 30. In this .. '.77742-7 arrangement, each sensing element 80 is threaded through the flexible body 32 between adjacent electrode segments 30. In the illustrated embodiment, the temperature sensing elements 80 comprise thermocouples. When the sensing element 80 comprises a thermocouple, an epoxy material 46, such as *Master Bond Polymer System EP32HT (Master Bond Inc., Hackensack, New Jersey), encapsulates the thermocouple junction 84, securing it to the flexible body 32.
Alternatively, the thermocouple junction 84 can be coated in a thin layer of polytetrafluoroethylene (PTFE) material.
When used in thicknesses of less than about 0.002 inch, these materials have the sufficient insulating properties to electrically insulate the thermocouple junction 84 from the associated electrode segment 30, while providing sufficient thermally conducting properties to establish thermal conductive contact with electrode segment 30. The use of such materials typically will not be necessary when thermistors are used, because conventional thermistors are already encapsulated in an electrically insulating and thermally conducting material.
In another alternative embodiment (as Figs. 10 and 11 show), the temperature sensing element 80 physically projects through an opening 86 in each electrode segment 30.
As in the embodiment shown in Fig. 24, the sensing elements 80 comprise thermocouples, and a thermally conducting and electrically insulating epoxy material encapsulates the thermocouple junction 84, securing it within the opening 86.
It should be appreciated that some sensing elements 80 can be carried by the electrode segments 30, while other sensing elements 80 can be carried *Trade-mark 21~~0~~ .
WO 96!00036 PCT/US94111748 between the element segments 30. Many combinations of sensing element locations are possible, depending upon particular requirements of the ablating procedure.
II. Temperature Sensing Thermocouples For Cardiac Ablation 71. On Soard Reference Thermocouple Each temperature sensing element 80 can comprise a thermistor or a thermocouple. Thermocouples are preferred because, when compared to now-conventional thermistors, a thermocouple is less expensive and presents a smaller, more compact profile. Still, as technology advances, smaller thermistors and other types of miniature temperature sensing elements may become available for use as described in this specification.
Multiple thermocouples can be electrically coupled to sense temperature conditions along an ablating element 10 in various ways. Figs. 12A; 12B
2o and 12C schematically show three representative embodiments.
In the preferred embodiment shown in Fig. 12A, multiple thermocouples (three of which are shown and designated T~ Z 3) are located at or near the ablating electrodes, respectively, E1, E2, and E3.
In conventional fashion, each thermocouple T~z3 includes two electrically insulated wires 34 and 36 of dissimilar metals.
Various types of dissimilar metals can be 3o selected to form the thermocouples T~z3. For example, nickel-10%, chromium can be electrically coupled to either constantan (forming a conventional Type E thermocouple) or nickel-5%(aluminum silicon) (forming a conventional Type K thermocouple); iron can be electrically coupled to constantan (forming 2~~4G~~
a conventional Type J thermocouple); platinum-13%
rhodium can be electrically coupled to platinum (forming a conventional Type R thermocouple);
platinum-10% rhodium can be electrically couple to platinum (forming a conventional Type S
thermocouple); or copper can be electrically coupled to constantan (forming a conventional Type T
thermocouple).
In Fig. 12A, the wires 34 are copper and wires SO 36 are constantan, thereby forming Type T
thermocouples. The wires 34 and 36 are electrically insulated, except for the region 84 where they are stripped of insulation and fused together. This region 84 is located at or near the associated electrode E1/E2/E3. This region 84 is encapsulated in an epoxy or PTFE material, as previously described, to electrically insulate the region 84 from the ablating electrode.
Voltage differences measured between the copper wire 34 and the constantan wire 36 of each thermocouple Ti 2 3 varies with the temperature of the junction region 84. The voltage increases or decreases as the temperature of the region 84, respectively, increases or decreases.
As Fig. 12A also shows, a single reference thermocouple TREE is electrically coupled in common to all three thermocouples T~z3. The reference tlxermocouple TREE is located in a region where a known temperature condition exists. This aspect will be described in greater detail-later.
In Fig. 12A, the reference thermocouple TREF
comprises a length of electrically insulated constantan wire 38, locally stripped of insulation and electrically coupled in parallel to the constantan wires 36 of the three thermocouples T~,2,3.
R'O 96!00036 219 4 Q 6 ~ PCTIUS94111748 The reference thermocouple T~F also includes a length of insulated copper wire 40, locally stripped of insulation and electrically coupled to the constantan wire 38.
The junction region of the constantan wire 38 and the copper wire 40 is the thermocouple junction 42 of the reference thermocouple T~F. This junction 42 is exposed to a known temperature condition. Like the junction regions 84 between the copper and constantan wires 34 and 36 of the other thermocouples Tt,z.3 (i.e., the regions 84), this junction region 42 of the reference thermocouple is also encapsulated in an epoxy or PTFE material that electrically insulates it from the ablating electrodes.
An external processing element 92 is electrically coupled to the thermocouples Tt,t.3 and TREE' The particular details of this connection can vary and will be described in greater detail later.
The processing element 92 registers the magnitudes of the voltage differences existing between the copper wire 40 of T~F and the copper wires 34 of each of the thermocouples T , which t.2.3 are respectively designated oVtZ,3 (in Fig. 12A). The processing element 92 derives from the voltage differences ~Vt,Z,3 the temperature condition at each thermocouple Tt,Z~3, using the following equation:
ovN
TEMP N TEMP~r. -where:
TEMPN is the temperature condition sensed by a selected thermocouple Tw (where N = l, 2 or 3 in Fig. 12A), the magnitude of which is not known.
T~REF is the temperature condition sensed ' . 77742-7 by reference thermocouple TREE, the magnitude of which is known.
~VN is the voltage difference between the copper wire 40 Of TREE and the copper wire 34 of the selected thermocouple TN, which is measured and known.
a is a known function (called the Seebeck coefficient), which expresses the relationship between voltage and temperature for the type of dissimilar metals used in the thermocouple.
Preferably, the processing element 92 includes a memory chip containing a look up table that inputs OVN and relates the expression OVN/a to TEMPN for the particular thermocouple type used. In this way, the processing element 92 directly converts a measured voltage difference OVN to a temperature TEMPN.
Fig. 12B schematically shows an alternative arrangement for electrically coupling three thermocouples Ti,z,3 for use in an ablating element. In Fig. 12B, individual lengths of copper wire 40 are electrically coupled in series with the constantan wires 36 of each thermocouple Tl,z,s, in the same manner described before. The individual junction regions 42 form three individual reference thermocouples TREE 1,2,31 one for each thermocouple Tl,z,3. These junction regions 42 are each individually encapsulated within an epoxy or PTFE material, as already described. The three individual reference thermocouples TREE 1,2,3 are commonly exposed to the same, known temperature condition.
As Fig. 12B shows, the temperature-related 21940~~
R'O 96100036 PCTIUS94/I1748 voltage differences ~V~,z,3 are measured between the copper wire 34 of a selected thermocouple T~,2,3 and the copper wire 40 of its associated reference thermocouple TREE 1,z,3~
Fig. 12C schematically shows another alternative arrangement for electrically coupling three thermocouples T~z3 for use in an ablating element.
In Fig. 12C, a single length of copper wire 40 is electrically coupled in parallel with the constantan wires 36 of each thermocouple T~,z,3. The individual electrical junction regions 42 form three individual reference thermocouples T , one for each REF t,z,3 thermocouple T~z3. As before described, the junction regions 42 are all individually encapsulated within an epoxy or PTFE material. As in the embodiment shown in Fig. 12B, the three individual reference thermocouples TREF i,z,3 are commonly exposed to the same, known temperature condition.
As Fig. 12C shows, the temperature-related voltage differences ~V~z,3 are measured between the copper wire 34 of a selected thermocouple T~z3 and the copper wire 40 of its associated reference thermocouple TREE 1,2,3 Conventional practice would locate the common reference thermocouple TREF in the Fig. 12A
embodiment and the three individual reference thermocouples TREF 1 2, 3 in the Figs. 12B and 12C
embodiments externally within the temperature processing element 92 itself. In these arrangements (which can be employed, if desired), the known temperature condition TEMPREF is the temperature to which the junction regions of the reference thermocouples are exposed. This ambient temperature condition can be measured by a thermistor in the processing element 92. Alternatively, a 21 ~ 4 ~3 ~,~
conventional compensation circuit can be used.
The common reference thermocouple TREE in the Fig. 12A embodiment and the three individual reference thermocouples T~F~,z,3 in the Figs. 12B and 12C can also be carried within the handle 16 of the catheter probe 14. In this arrangement, the known temperature condition TEMPREF is the temperature to which the junction regions 42 of the reference thermocouples are exposed in the handle 16. This temperature condition can be measured by a thermistor in the handle 16 (not shown), or using a conventional compensation circuit. However, in the illustrated and preferred embodiment, the common reference thermocouple TREE in the Fig. 12A
embodiment and the three reference thermocouples TREE
~, z 3 in the Figs. 12B and 12C embodiments are carried onboard the catheter body 12 for exposure to the blood pool in the body. In this preferred arrangement, all reference thermocouples are exposed to blood temperature, either by being located in a heart chamber, or by being located elsewhere in the vascular system of the patient where the catheter body lies. TEMPREF or TEMPREF(l,z,s> thereby is at or near 37°C.
Figs. 13 and 14A show one preferred structural implementation of an onboard reference thermocouple in the arrangement shown schematically in Fig. 12A.
As Fig. 13 shows, a coupler member 94 carried by the catheter body 12 comprises the common reference thermocouple TREE The coupler member 94 is made of a biocompatible, thermally conductive material, like stainless steel or platinum.
As Fig. 13 shows, the coupler member 94 is secured in line onboard the catheter body 12 in a region spaced away from the ablating electrodes E1, E2, and E3. As before described, the coupler member 94 can either be located inside a heart chamber (as Fig. 13 shows), or elsewhere away from the ablating element 10 in the patient s vascular system where the catheter body 12 extends.
If located within the heart chamber itself (as Fig. 13 shows), the coupler member 94 should be spaced far enough away from the electrode elements E1/E2/E3 so that the blood pool contacting the coupler member 94 will not be subject to the localized blood heating effects of the ablation procedure. In this situation, as when the coupler member 94 is more distantly located,outside the heart chamber, the temperature of the blood pool contacting the coupler member 94 will remain essentially constant at about 37° C during the ablation procedure.
As Fig. 14A shows in detail, the coupler member 94 includes an interior bore 96, which is coated with an electrically insulating material 95. A ring 98 is seated in a groove 100 within the bore 96.
The coupler member 94 and ring 98 can comprise a one-piece assembly (as Fig. 14A shows). In this arrangement, the ring 98 includes a split 102 for reducing its diameter, so it can be pressed into and compression-fitted in place within the groove 100.
Alternatively, the coupler member 94 can comprise a two part body, separable along the groove 100, to allow placement of the ring 98. These arrangements allow the electrical connections to the ring 98 to be made outside the member 94, before placement therein.
In the embodiment shown in Fig. 14A, the ring 98 is made of constantan metal. The ring 98 thereby structurally corresponds to the length of constantan wire 38 shown in Fig. 12A, to which the constantan wires 36 of the three thermocouples T~,z3 are electrically coupled in parallel, as Fig. 14A shows.
The length of copper wire 40 (as shown in Fig. 12A) is electrically coupled to the ring 98 (as Fig. 14A
also shows).
This copper wire 40 and the copper wires 34 from each thermocouple T~,Z 3 pass through the bore of the catheter body 12 to the external temperature processing element 92 (via the external connector 104 carried on the handle 16, as Fig. 1 shows. The coupler member 94 and ring 98 thereby serve as an in-line reference thermocouple T~F common to the thermocouples Ti Z, 3' Fig. 14B shows an alternative embodiment for the coupler member 94 that is free of an interior ring 98. In Fig. 14B, the exterior surface of the coupler member 94 is coated with an epoxy or TFE material 106, as previously described. The material 106 bonds the catheter body 12 to the opposite ends of the coupler member 94. The material 106 also electrically insulates the coupler member 94 from the ablating electrodes 30.
The coupler member 94 in Fig. 14B also includes an interior bore 96. The bore 96 has an inner surface region where a layer 108 of constantan material is applied. This layer 108 corresponds to the length of constantan wire 40 shown in Fig. 12A, to which the constantan wires 36 of the three thermocouples T~2,3 are electrically coupled in parallel. The copper wire 40 for the reference thermocouple TREE is also fused to the constantan layer 108.
The constantan ring 98 in Fig. 14A and the constantan layer 108 in Fig. 14B collectively couple 2~9ao~z the constantan wires 34 of each electrode thermocouple T~, 2, 3 to the copper wire 40 of the reference thermocouple TREE. It thereby simplifies electrical connections within the~confined interior regions of-the small diameter of the catheter body 12. The constantan ring 98 and layer 108 also eliminate the need to pass the constantan wires 36 of each electrode thermocouple T~, z, 3 through the entire length of the catheter body 12.
The temperature condition that the onboard reference thermocouple T~F senses is the essentially constant temperature of the blood pool, which the coupler member 94, exposed to the blood pool, thermally conducts. The reference temperature TENHIpREF is thereby not subject to sudden change or variance, as external ambient air temperature can be. Greater accuracy results.
Figs. 15A and 15B show an alternative embodiment for using a single reference thermocouple. The constantan wire 36 from the thermocouples T~,Z,3 are connected together by either a weld or solder connection to the constantan wire 38 in a star configuration (shown in Figs. 15A/B), although other configurations (such as a ladder configuration) can be used. The reference thermocouple TRFF can then be placed under a ring, just like the thermocouples used for temperature sensing. All the thermocouple wires are then wrapped in a tube 114 to thermally and electrically insulate them from the RF wires (not shown). Fig. 15B is the schematic representation of the star connection of Fig 15A.
Figs. 16A and 16B show a preferred structural implementation of multiple onboard reference thermocouples TREE x,2,3 electrically coupled in the arrangement shown schematically in Fig. 12B. As 2194p62 Fig. 16A shows, the three reference thermocouples TftEF 7,2,3 are individually threaded through the catheter body 12 and encapsulated in a electrically insulating and thermally conducting epoxy bubble 110. Preferably, the thermocouples TREE ~,z,3 are spaced closely together.
As Fig. 16B shows, the number of wires entering the processing element 92 is reduced from six to four by electrically coupling the three copper wires 40 associated with the reference thermocouples TREE
within the handle 16 of the probe. This forms a single copper wire 112 common to all the reference thermocouples. The common reference copper wire 112 and the three other copper wires 34 of the theL-mocouples T~,23, are connected to the processing element 92 (as Fig. 16B shows). In this arrangement (as Fig. 16B further shows), ~V~,23 is measured between the individual copper wires 34 for each thermocouple T~23 and the common reference copper wire 112 of the reference thermocouples TREFt,z,a.
The arrangement of multiple onboard reference thermocouples TREY ~,2 3 in the arrangement shown schematically in Fig. 12C can be structurally carried out using a coupler member 94 and ring 98 assembly identical to the one shown in Fig. 14, except that the ring 98 is made of copper metal to correspond to the common copper wire 4O shown Fig.
12C. Alternatively, the multiple onboard reference thermocouples TpEF 1,2,3 in the arrangement shown schematically in Fig. 12C can be structurally implemented using the ring-free coupler member 94 shown in Fig. 15, except that the layer 108 within the coupler bore 96 is made of copper metal to correspond to the common copper wire 40 shown in Fig. 12C.
All of-the thermocouple assemblies described in Figs. 12A, B, and C require an initialization before conducting an ablation procedure. The temperature processing element 92 goes through this initialization phase to compensate for offsets in the voltage differences~V~,Z3 at blood temperature.
Durinq the ablating procedure, the temperature processing element 92 registers the individual change in voltage ~V~,z,3. The temperature processing element 92 applies the associated offset and then converts the resulting change in voltages OV~,Z,3 to temperature readings, using a pre-established look-up table, as already described.
The temperature processing element 92 preferably displays as output the temperature conditions sensed along the ablating element 10. The multiple sensed temperature conditions can also be used in a feedback control loop to control the ablation process itself. This aspect of the invention will be described in greater detail later.
In the preferred embodiment, regardless of the particular type of thermocouple used and the manner in which it is electrically wired within the catheter body 12, the wires 34/36 and 38/40 serving the thermocouples are wrapped in a tube 114 (see Fig. 16A) of thermally insulating material, like polyimide. The tube 114 thermally insulates the thermocouple wires from other wires in the body that carry ablating energy. Thus, the thermocouple wires are thermally insulated Prom heat that may be generated within the catheter body 12 by the transfer of ablating energy to the energy emitting regions at the distal end of the catheter body. The temperature-indicating voltages generated by the thermocouples are thereby not altered by exposure of 2194~6,~
R'O 96/00036 PCTIUS94/11748 the thermocouple wires to this source of heat within the catheter body.
B. Lov Profile composite Thermocouple Fig. 17 shows a composite, low profile thermocouple 116 that can be used in association with all types of flexible ablating elements 10.
The thermocouple 116 comprises a thin, semi-flexible substrate ll8.formed of an electrically insulating material, like polyimide. In the illustrated embodiment, the substrate 118 is tubular in shape.
Of course, other shapes could be used.
Two electrical conductive pathways 120 and 122 extend along the surface of the substrate 118. The pathways 120 and 122 can be applied by conventional sputter coating techniques or an ion beam assisted deposition (IBAD) process. Alternatively, small gauge wires of these different metal materials could be embedded within the tubular substrate during its extrusion or molding.
Each pathway 120 and 122 comprises a different electrically conductive metal material. Preferably, one pathway 120 is formed by applying copper, and the other pathway 122 is formed by applying constantan.
The ends of the two pathways 120 and 122 are electrically fused together on the substrate 118.
In the illustrated and preferred embodiment, a band 124 of metal material of one of the pathways 120 and 122 spans the ends of the pathways 120 and 122, electrically fusing them together. This band 124 forms a thermocouple junction on the surface of the substrate 118. Small gauge wires 126 and 128 of matching metal material are electrically coupled to the opposite ends of the pathways 120 and 122.
A thin, outer electrically insulating layer 130 is applied over the pathways 120 and 122 and thermocouple band 124 to complete the assembly of the low profile thermocouple 116.
Additional pathways 120/122, bands 124, and wires 126/128 can be applied to a single substrate 118 to form multiple thermocouple junctions on it.
As Fig. 18 shows, the semi-flexible thermocouple 116 can be made small enough in diameter to fit within the structure l0 beneath or near an ablating element 30. Alternatively, the thermocouple 116 can be made large enough in diameter to fit over the flexible body 32, as Fig. 18 also shows.
III. Control of Cardiac Ablation Bsing Multiple Temperature Feedback Control Fig. 19 shows, in schematic form, a system 200 for applying ablating energy by multiple emitters based, at least in part, upon local temperature conditions sensed by multiple sensing elements 80.
In Fig. 19, the multiple sensing elements 80 2o comprise thermocouples 208, 209, and 210 individually associated with the multiple emitters of ablating energy, which comprise electrode regions 201, 202, and 203. The system 200 also includes a common reference thermocouple 211 carried within the coupler element 211 for exposure to the blood pool, as previously described. Alternatively, other kinds of temperature sensing elements can be used, like, for example, thermistors, fluoroptic sensors, and resistive temperature sensors, in which case the 3o reference sensor 211 would typically not be required.
The system 200 further includes an indifferent electrode 219 for operation in a uni-polar mode.
The ablating energy emitters 201, 202, 203 can comprise the rigid electrode segments 3o previously R'O 96100036 PCT/US94111748 described. Alternatively, the electrode regions 201, 202, 203 can comprise a continuous or segmented flexible electrode of wrapped wire or ribbon. It should be appreciated that the system 200 can be used in association with any ablating element that employs multiple, independently actuated ablating elements.
The system 200 includes a source 217 of ablating energy. In Fig. 19, the source 217 generates radio frequency (RF) energy. The source 217 is connected (through a conventional isolated output stage 216) to an array of power switches 214, one for each electrode region 201, 202, and 203. A connector 212 (carried by the probe handle) electrically couples each electrode region 201, 203, 203 to its own power switch 214 and to other parts of the system 200.
The system 200 also includes a microcontroller 231 coupled via an interface 230 to each power switch 214. The microcontroller 231 turns a given power switch 214 on or off to deliver RF power from the source 217 individually to the electrode regions 201, 202, and 203. The delivered RF energy flows from the respective electrode region 201, 202, and 203, through tissue, to the indifferent electrode 219, which is connected to the return path of the isolated output stage 216. .
The power switch 214 and interface 230 configuration can vary according to the type of ablating energy being applied. Fig. 20 shows a representative implementation for applying RF
ablating energy.
In this implementation, each power switch 214 includes an N-MOS power transistor 235 and a P-MOS
power transistor 236 coupled in between the respective electrode region 201, 202, and 203 and zl~~o~z R'O 96/00036 PCTlUS94111748 the isolated output stage 216 of the power source a17.
A. diode 233 conveys the positive phase of RF
ablating energy to the electrode region. A diode 234 conveys the negative phase of the RF ablating energy to the electrode region. Resistors 237 and 238 bias the N-MOS and P-MOS power transistors 235 and 236 in conventional fashion.
The interface 230 for each power switch 214 includes two NPN transistors 239 and 240. The emitter of the NPN transistor 239 is coupled to the gate of the N-MOS power transistor 235. The collector of the NPN transistor 240 is coupled to the gate of the P-MOS power transistor 280.
The interface for each power switch 214 also includes a control bus 243 coupled to the microcontroller 231. The control bus 243 connects each power switch 214 to digital ground (DGND) of the microcontroller 231. The control bus 243 a lso includes a (+) power line (+5V) connected to the collector of the NPN transistor 239 and a (-) power line (-5V) connected to the emitter of the NPN
interface transistor 240.
The control bus 243 for each power switch 214 further includes an EgE~ line. The base of the NPN
transistor 239 is coupled to the ESE~ line of the control bus 243. The base of the NPN transistor 240 is also coupled the E~~ line of the control bus 243 via the Zener diode 241 and a resistor 232. ESE~
line connects to the cathode of the Zener diode 241 through the resistor 232. The Zener diode 241 is selected so that the NPN transistor 240 turns on when Esc exceeds about 3 volts (which, for the particular embodiment shown, is logic 1).
It should be appreciated that the interface 230 z ~ q4a6z can be designed to handle other logic level standards. In the particular embodiment, it is designed to handle conventional TTL (transistor transfer logic) levels.
The microcontroller 231 sets EsE~ of the control bus 243 either at logic 1 or at logic 0. At logic 1, the gate of the N-MOS transistor 235 is connected to (+) 5 volt line through the NPN transistors 239.
Similarly, the gate of the P-MOS transistor 236 is connected to the (-) 5 volt line through the NPN
transistor 240. This conditions the power transistors 235 and 236 to conduct RF voltage from the source 217 to the associated electrode region.
The power switch 214 is "on."
When the microcontroller 231 sets ESE~ at logic 0, no current flows through the NPN transistors 239 and 240. This conditions the power transistors 235 and 236 to block the conduction of RF voltage to the associated electrode region. The power switch 214 i8 ~Off."
The system 200 (see Fig. 19) further includes two analog multiplexers (MUX) 224 and 225. The multiplexers 224 and 225 receive voltage input from each thermocouple 208, 209, 210, and 211. The microcontroller 231 controls both multiplexers 224 and 225 to select voltage inputs from the multiple temperature sensing thermocouples 208, 209, 210, and 211.
The voltage inputs from the thermocouples 208, 209, 210, and 211 are sent to front end signal conditioning electronics. The inputs are amplified by differential amplifier 226, which reads the voltage differences between the copper wires of the thermocouples 208/209/210 and the reference thermocouple 211. The voltage differences are 219~Q~~
W~ 96/00036 PCTIU894111748 conditioned by element 227 and converted to digital codes by the analog-to-digital converter 228. The look-up table 229 converts the digital codes to temperature codes. The temperature codes are read by the microcontroller 231.
The microcontroller 231 compares the temperature codes for each thermocouple 208, 209, and 210 to preselected criteria to generate feedback signals.
The preselected criteria are inputted through a user interface 232. These feedback signals control the interface power switches 214 via the interface 230, turning the electrodes 201, 202, and 203 off and on.
The other multiplexer 225 connects the thermocouples 208, 209, 210, and 211 selected by the microcontroller 231 to a temperature controller 215.
The temperature controller 215 also includes front end signal conditioning electronics, as already described with reference to elements 226, 227, 228, and 229. These electronics convert the voltage differences between the copper wires of the thermocouples 208/209/210 and the reference thermocouple 211 to temperature codes. The temperature codes are read by the controller and compared to preselected criteria to generate feedback signals. These feedback signals control the amplitude of the voltage (or current) generated by the source 217 for delivery to the electrodes 201, 202, and 203.
Based upon the feedback signals of the microcontroller 231 and the temperature controller 215, the system 200 distributes power to the multiple electrode regions 201, 202, and 203.to establish and maintain a uniform distribution of temperatures along the ablating element. In this way, the system 200 obtains safe and efficacious .. . 77742-7 lesion formation using multiple emitters of ablating energy.
The system 200 can control the delivery of ablating energy in different ways. Several representative modes will now be described.
Individual Amplitudes/Collective Duty Cycle The electrode regions 201, 202, and 203 will be symbolically designated E(J), where J represents a given electrode region (J=1 to N).
As before described, each electrode region E(J) has at least one temperature sensing element 208, 209, and 210, which will be designated S(J,K), where J represents the electrode region and K represents the number of temperature sensing elements on each electrode region (K=1 to M).
In this mode (see Fig. 21), the microcontroller 316 operates the power switch interface 230 to deliver RF power from the source 217 in multiple pulses of duty cycle 1/N.
With pulsed power delivery, the amount of power PE(J) conveyed to each individual electrode region E(J) is expressed as follows:
2 0 PE cJ> ~ AMPS cJ~ 2 x DUTYCYCLEE ~J) where:
AMPEtJ> is the amplitude of the RF voltage conveyed to the electrode region E(J), and ~. 77742-7 - 35a -DUTYCYCLEE~J) is the duty cycle of the pulse, expressed as follows:
DUTYCYCLE _ TONES,) ') TONE~~) +TOFFE~~) where:
R'O 96/00036 PCT/US94111748 TONE~~~ is the time that the electrode region E(J) emits energy during each pulse period, TOFFE~~~ is the time that the electrode region E(J) does not emit energy during each pulse period.
The expression TONE~~~ + TOFFE~~~ represents the period of the pulse for each electrode region E(J).
In this mode, the microcontroller 231 collectively establishes duty cycle (DUTYCYCLF~~~~) of 1/N for each electrode region (N being equal to the number of electrode regions).
The microcontroller 231 may sequence successive power pulses to adjacent electrode regions so that the end of the duty cycle for the preceding pulse overlaps slightly with the beginning of the duty cycle for the next pulse. This overlap in pulse duty cycles assures that the source 217 applies power continuously, with no periods of interruption caused by open circuits during pulse switching between successive electrode regions.
2o In this mode, the temperature controller 215 makes.individual adjustments to the amplitude of the RF voltage for each electrode region (AMPE~~~) , thereby individually changing the power PE~~~ of ablating energy conveyed during the duty cycle to each electrode region, as controlled by the microcontroller 231.
In this mode, the microcontroller 231 cycles in successive data acquisition sample periods. During each sample period, the microcontroller 231 selects individual sensors S(J,R), and voltage differences are read by the controller 215 (through MITX 225) and converted to temperature codes TEN~(J).
When there is more than one sensing element associated with a given electrode region, the controller 215 registers all sensed temperatures for the given electrode region and selects among these the highest sensed temperature, which constitutes T1~(J). The temperature sensing element providing the highest sensed temperature for a given electrode region is the one in most intimate contact with heart tissue. The lower sensed temperatures of the ottner sensing elements on the given electrode region indicate that the other sensing elements are not in such intimate contact, and are instead exposed to connective cooling in the blood pool.
In this mode, the controller 215 compares the temperature TE~(J) locally sensed at each electrode E(J) during each data acquisition period to a setpoint temperature TEMPgEr established by the physician. Based upon this comparison, the controller 215 varies the amplitude AMPE~~~ of the RF
voltage delivered to the electrode region E(J), while the microcontroller 231 maintains the DUTYCYCLF~~~~ for that electrode region and all other electrode regions, to establish and maintain TEMP(J) at the setpoint temperature TEMPSET.
The set point temperature TEMPser can vary according to the judgment of the physician and empirical data. A representative set point temperature for cardiac ablation is believed to lie in the range of 40°C to 95° C, with 70° C being a representative preferred value.
The manner in which the controller 215 governs AMPE~~~ can incorporate proportional control methods, proportional integral derivative (PID) control methods, or fuzzy logic control methods.
For example, using proportional control methods, if the temperature sensed by the first sensing element TEMP(1) > TEMPser , the control signal generated by the controller 215 individually reduces 21~~J~2 R'O 96100036 PCTIUS94111748 the amplitude AMPE~» of the RF voltage applied to the first electrode region E(1), while the microcontroller 231 keeps the collective duty cycle DUTYCYCLEE~» for the first electrode region E(1) the same. If the temperature sensed by the second sensing element TEMP(2) < TEI4P5~ , the control signal of the controller 215 increases the amplitude AMPE~z~ of the pulse applied to the second electrode region E(2), while the microcontroller 231 keeps the collective duty cycle DUTYCYCLEE~z~ for the second electrode region E(2) the same as DUTYCYCLEE~», and so on. If the temperature sensed by a given sensing element is at the set point temperature TEMPsEr, no change in RF voltage amplitude is made for the associated electrode region.
The controller 215 continuously processes voltage difference inputs during successive data acquisition periods to individually adjust AMPE~~~ at each electrode region E(J), while the microcontroller 231 keeps the collective duty cycle the same for all electrode regions E(J). In this way, the mode maintains a desired uniformity of temperature along the length of the ablating element.
Using a proportional integral differential (PID) control technique, the controller 215 takes into account not only instantaneous changes that occur in a given sample period, but also changes that have occurred in previous sample periods and the rate at which these changes are varying over time. Thus, using a PID control technique, the controller 215 will respond differently to a given proportionally large instantaneous difference between TEMP (J) and TEMPgET, depending upon whether the difference is getting larger or smaller, compared to previous 2p940b~
instantaneous differences, and whether the rate at which the difference is changing since previous sample periods is increasing or decreasing.
Collective Amps;tuda/Tnd~v;dua~ Dutv Cvclaa In this feedback mode (see Fig. 22), the controller 215 governs the source 217 to collectively control the RF voltage amplitude AMPE~~~
for all electrode regions based upon the lowest local temperature sensed TEMPSHIN. At the same time, in this feedback mode, the microcontroller 231 individually alters the power conveyed to the electrode regions where temperatures greater than TEMP~~N are sensed, by adjusting the duty cycle DUTYCYCLEE~~~ of these electrode regions.
In this mode, as in the previous mode, the microcontroller 231 separates the power into multiple pulses. Initially, each pulse has the same duty cycle (DUTYCYCLEE~~~) of 1/N. As in the previous mode, the application of successive RF pulses to adjacent electrode regions may be timed to overlap so that the source 318 applies power continuously to the electrode regions E(J).
The controller 215 circles in successive data acquisition periods to sequentially read the temperature sensed by each sensing element TEMP(J).
When there are multiple sensing elements associated with each electrode region, the controller 215 registers all sensed temperatures for the particular electrode and selects among these the highest sensed temperature, which is TEMP(J).
In this mode, the controller 215 compares, during each data acquisition period, the individual temperatures sensed TEMP(J) to the set point temperature TEMP~Er. The controller 215 also selects R'O 96/00036 PCT/US94111748 the lowest sensed temperature TEMPsHIN. The controller-215 adjusts AMPE~~~ to maintain TEMP~IN =
TEMPSEr, using proportional, PID, or fuzzy logic control techniques. At the same time, the microcontroller 231 adjusts DUTYCYCLEE~~~ of the electrode regions where TEMP(J) > TEMPawIN to maintain TEMP (J) = TEMP ser' For example, using only proportional control techniques, if TEMPsHIN < TEMPsEr~ the controller 215 collectively increases the amplitude of the RF
voltage of all electrode regions, based upon the difference between TEMPsMIN and TEMPSET (~TEMPSHIN/SEr) ~
until TEMPsNtN > TEMPsET.
During this time (when TEMPsNIN remains below TEMPsEr), the microcontroller 231 also controls the application of power to the other electrode regions E(J) where the local sensed temperature TEMP(J) is above TEMPsNIN, as follows:
(i) if TEMP(J) < TEMPser , the microcontroller 231 increases the duty cycle of the power applied to the electrode region E(J) at the RF voltage amplitude established by ~T~SNIN/SET' (ii) if TEMP(J) > TEMPser , the microcontroller 231 decreases the duty cycle of the power applied to the electrode region E(J) at the RF voltage amplitude established by ~T~sNIN/sEr' (iii) if TEMPs~NI = TEMPsET , the microcontroller 231 maintains the duty cycle for the given electrode region E(N) at the RF voltage amplitude established by ~TI~SMIN/SEr' When TEMPsHIN > TEMPsEr, the controller 215 collectively reduces the RF voltage amplitude delivered to all electrode regions. When TEI~~IN =
2~9~o~z WO 96/00036 PCT/US9411f748 TEMPsfT, the controller 215 collectively maintains the then-established RF voltage amplitude delivered to all electrode regions.
T_emoerat~e Control with Hysterp~i.
In this mode (see Fig. 23), as in the previous modes, the system 200 cycles in successive data acquisition periods to sequentially register the temperature sensed by the sensing elements TEMP(J) for the electrode regions E(J). As before, when there are multiple sensing elements associated with each electrode region, the system 200 registers all sensed temperatures for the particular electrode region and selects among these the highest sensed temperature, which becomes TEMP(J).
In this mode, the microcontroller 231 compares the temperature sensed locally at each electrode region TENIP(J) during each data acquisition period to high and low threshold temperatures TEMPHireRese and 2O T'~P~~HRESH~ where T~ az~trsx'T~PSZ~,.INCR
where T~ ioo-mmrsx'T~sEx,-INCR
T~SET is the set point temperature, and INCR is a preselected increment.
When operated in this mode, the microcontroller 231 operates the power switch interface 230 to turn a given electrode region E(J) off when the local temperature sensed at that electrode region TEMP(J) z TEMPNITHRESN~ The microcontroller 231 keeps the electrode region turned off until the locally sensed temperature TEMP (J) drops below TEMPi~HRESH' The microcontroller 231 turns a given electrode region 2 ~ q4a~~
R'O 96/00036 PCTlUS94111748 E(J) on and supplies power at a selected voltage amplitude when the local temperature sensed at that electrode region TEMP (J) < TEMPi~HRESH~
The values for TEMPT and INCR can vary according to the judgment of the physician and empirical data.
As before stated, a representative value for TEMPsEr is believed to lie in the range of 40°C and 95°C, with a preferred value of 70°C. A representative value of INCR is believed to lie in the range of 2°C
to 8°C, with a preferred representative value of around 5°C.
In this implementation, the controller 215 establishes a constant RF voltage amplitude sufficiently high to maintain the desired temperature conditions during hysteresis.
Alternatively, the controller 215 can have the capability to adjust voltage should the coolest sensed temperature TEMP~~N decrease below a selected lower limit below TEMP~~HRESH ~ or should the longest duty cycle exceed a predetermined value. It should be appreciated that there are other ways of adjusting and maintaining the amplitude while the hysteresis control method is carried out.
Diftereatial Temperature Disablinc In this mode (see Fig. 24), the temperature controller 215 selects at the end of each data acquisition phase the sensed temperature that is the greatest for that phase (TEMP). The temperature controller 215 also selects for that phase the sensed temperature that is the lowest (TEMP~Iw).
The controller 215 compares the selected hottest sensed temperature TEMPS to a selected high set point temperature TEMPH». The comparison generates a control signal that collectively adjusts the 2~~4Q~.~
R'O 96f00036 PCTIU594111748 amplitude of the RF voltage for all electrodes using proportional, PID, or fuzzy logic control techniques.
In a proportion control implementation scheme:
(i) If TEMPS > TEMPHiser , the control signal collectively decreases the amplitude of the RF voltage delivered to all electrode regions;
(ii) If TEMPs~x < TEMPNISET . the control signal collectively increases the amplitude of the RF voltage delivered to all electrode regions:
(iii) If TEIHP~ = TEMPNtseT . no change in the amplitude of the RF voltage delivered to all electrode regions is made.
It should be appreciated that the temperature controller 215 can select for amplitude control purposes any one of the sensed temperatures TEMP, TEMP~tN, or temperatures in between, and compare this temperature condition to a preselected temperature condition.
Working in tandem with the amplitude control function of the temperature controller 215, the microcontroller 231 governs the delivery of power to the electrode regions based upon difference between a given local temperature TEMP (J) and TEMP~tN. This implementation computes the difference between local sensed temperature TEMP(J) and TEMP~IN and compares this difference to a selected set point temperature difference pTEMP~T. The comparison generates a control signal that governs the delivery of power to the electrode regions.
If the local sensed temperature TEMP(J) for a given electrode region E(J) exceeds the lowest R'O 96100036 PCT/US94111748 sensed temperature TEMP~~N by as much as or more than ATEMPSEr (that is, if TEMP (J) - TEMP~IN x ATEMPSEr), the microcontroller 231 turns the given electrode region E(J) off. The microcontroller 231 turns the given electrode E(J) back on when TEMP(J) - TEMP~IN
~T~SET' Alternatively (see Fig. 25), instead of comparing TEMP(J) and TEMP~~N, the microcontroller 231 can compare TEMPS and TEMPyx~N. When the l0 difference between TEMPS and TEMP~~N equals or exceeds a - predetermined amount ~TEMPSEr, the controller 231 turns all electrode regions off, except the electrode region where TEMP~~N exists.
The controller 231 turns these electrode regions back on when the temperature difference between TEMPS and TEMP~Iw is less than ATEMPser' Some of the above-described temperature-based control schemes alter power by adjusting the amplitude of the RF voltage. It should be appreciated that, alternatively, power can be altered by the adjusting the amplitude of RF
current. Therefore, the quantity AMPE~~~ used in this Specification can mean either RF voltage amplitude or RF current amplitude.
III. Selecting Among Multiple Temperature sensing Elements As previously described, a given electrode region can have more than one temperature sensing element associated with it. In the previously descibed ablation control modes, the controller 215 registers all sensed temperatures for the given electrode region and selects among these the highest sensed temperature, which constitutes TEMP(J).
There are alternative ways of making this selection.
vincr PradictedKottea Because of the heat exchange between the tissue and the electrode region, the temperature sensing elements may not measure exactly the maximum temperature at the region. This is because the region of hottest temperature occurs beneath the surface of the tissue at a depth of about 0.5 to 2.0 mm from where the energy emitting electrode region (and the associated sensing element) contacts the tissue. If the power is applied to heat the tissue too quickly, the actual maximum tissue temperature in this subsurface region may exceed 100° C and lead to tissue desiccation.
Fig. 26 shows an implementation of a neural network predictor 300, which receives as input the temperatures sensed by multiple sensing elements S(J,K) at each electrode region, where J represents a given electrode region (J = 1 to N) and K
represents the number of temperature sensing 2o elements on each electrode region (K = 1 to M). The predictor 300 outputs a predicted temperature of the hottest tissue region T~PRE~(t). The controller 215 and microcontroller 231 derive the amplitude and duty cycle control signals based upon T~PRED(t)~ in the same manners already described using T1~(J).
The predictor. 300 uses a two-layer neural network, although more hidden layers could be used.
As shown in Fig. 26, the predictor 300 includes a first and second hidden layers and four neurons, designated N~~,X~, where 1, identifies the layer 1 or 2 and X identifies a neuron on that layer. The first layer (Iri) has three neurons (X = 1 to 3), as follows N~~ »; N~~ Z~; and N~~ 3~. The second layer (L=2) comprising one output neuron (X=1), designated N~2 ~~.
~~.77742-7 Temperature readings from the multiple sensing elements, only two of which - TS1(n) and TS2(n) - are shown for purposes of illustration, are weighed and inputted to each neuron N(1,1); N(1,2); and N(1,3) of the first layer.
Fig. 26 represents the weights as WL(x,N), where L=1; k is the input sensor order; and N is the input neuron number 1, 2, or 3 of the first layer.
The output neuron N(2,1) of the second layer receives as inputs the weighted outputs of the neurons N(1,1);
N(1,2); and N(1,3). Fig. 26 represents the output weights as WL(o,x). where L=2; O is the output neuron 1, 2, or 3 of the first layer; and X is the input neuron number of the second layer. Based upon these weighted inputs, the output neuron N(2,1) predicts T~pRED(t) The predictor 300 must be trained on a known set of data containing the temperature of the sensing elements TS1 and TS2 and the temperature of the hottest region, which have been previously acquired experimentally. For example, using a back-propagation model, the predictor 300 can be trained to predict the known hottest temperature of the data set with the least mean square error. Once the training phase is completed, the predictor 300 can be used to predict T~pRED(t) -Other types of data processing techniques can be used to derive TMpxpgEDct) . See, e.g. , US Patent No. 5, 906, 614, which is entitled "Tissue Heating and Ablation Systems and Methods Using Predicted Temperature for Monitoring and Control".
The illustrated and preferred embodiments use digital processing controlled by a computer to analyze information and generate feedback signals.
219~Ob2 It should be appreciated that other logic control circuits using micro-switches, AND/OR gates, inverters, anolog circuits, and the like are equivalent to the micro-processor controlled techniques shown in the preferred embodiments.
Various features of the invention are set forth in the following claims.
r
Claims (19)
1. A system for ablating body tissue, comprising:
multiple emitters of ablating energy;
at least one temperature sensing element at each energy emitter for measuring temperature at the energy emitter, a power controller coupling a source of ablating energy to each energy emitter to convey ablating energy to the energy emitters;
a processing element for periodically reading the temperature measured by each temperature sensing element and selecting one of the measured temperatures based upon preestablished criteria for comparison to at least one predetermined temperature to generate a signal; and a temperature controller coupled to the power controller for controlling the conveyance of ablating energy to the energy emitters based upon the signal.
multiple emitters of ablating energy;
at least one temperature sensing element at each energy emitter for measuring temperature at the energy emitter, a power controller coupling a source of ablating energy to each energy emitter to convey ablating energy to the energy emitters;
a processing element for periodically reading the temperature measured by each temperature sensing element and selecting one of the measured temperatures based upon preestablished criteria for comparison to at least one predetermined temperature to generate a signal; and a temperature controller coupled to the power controller for controlling the conveyance of ablating energy to the energy emitters based upon the signal.
2. A system according to claim 1, wherein the power controller individually couples each energy emitter to the source of ablating energy to convey ablating energy individually to each energy emitter in a sequence of power pulses, each power pulse having a duty cycle and an amplitude, wherein power delivered to each energy emitter for ablating tissue is expressed as follows:
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE;
the processing element compares the temperature measured by each temperature sensing element to the predetermined temperature and generates a signal individually for each energy emitter based upon the comparison; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the temperatures at all energy emitters essentially at the predetermined temperature during tissue ablation.
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE;
the processing element compares the temperature measured by each temperature sensing element to the predetermined temperature and generates a signal individually for each energy emitter based upon the comparison; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the temperatures at all energy emitters essentially at the predetermined temperature during tissue ablation.
3. A system according to claim 2, wherein the temperature controller varies the power pulse by individually varying the amplitude of the power pulse based upon the signal for that energy emitter, while maintaining the duty cycle of the power pulses essentially the same for all energy emitters.
4. A system according to claim 3, wherein the duty cycle is 1/N, where N is the number of energy emitters.
5. A system according to claim 3, wherein the temperature controller varies amplitude by varying either voltage or current.
6. A system according to claim 3, wherein the temperature controller individually turns off an energy emitter when the temperature measured at the energy emitter equals or exceeds the predetermined temperature by a predetermined amount and individually turns on the energy emitter when the temperature measured at the energy emitter is less than the predetermined temperature by a predetermined amount.
7. A system according to claim 2, wherein the temperature controller varies the power pulse by individually varying the duty cycle of the energy emitter based upon the signal for that energy emitter, while maintaining the amplitude of the power pulses essentially the same for all energy emitters.
8. A system according to claim 7, wherein the temperature controller individually turns off an energy emitter when the temperature measured at the energy emitter equals or exceeds the predetermined temperature by a predetermined amount and individually turns on the energy emitter when the temperature measured at the energy emitter is less than the predetermined temperature by a predetermined amount.
9. A system according to claim 2, wherein the temperature controller varies the power pulse by individually varying both the duty cycle and the amplitude of the power pulse for each energy emitter based upon the signal for that energy emitter.
10. A system according to claim 9, wherein the temperature controller individually turns off an energy emitter when the temperature measured at the energy emitter equals or exceeds the predetermined temperature by a predetermined amount and individually turns on the energy emitter when the temperature measured at the energy emitter is less than the predetermined temperature by a predetermined amount.
11. A system according to claim 9, wherein the temperature controller varies amplitude by varying either voltage or current.
12. A system according to claim 1, wherein each energy emitter defines an energy emitting zone E(J);
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), AMP E(J) being set to be essentially the same for all E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E (J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for identifying the lowest read temperature condition TEMP SMIN of all TEMP(J) and means for comparing the lowest read temperature condition TEMP SMIN to the predetermined temperature condition, designated TEMP SET, and the signal is based upon the comparison; and the temperature controller varies the power pulse to each zone E(J) based upon signal by varying AMP E(J) for all E(J) to maintain TEMP SMIN = TEMP SET.
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), AMP E(J) being set to be essentially the same for all E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E (J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for identifying the lowest read temperature condition TEMP SMIN of all TEMP(J) and means for comparing the lowest read temperature condition TEMP SMIN to the predetermined temperature condition, designated TEMP SET, and the signal is based upon the comparison; and the temperature controller varies the power pulse to each zone E(J) based upon signal by varying AMP E(J) for all E(J) to maintain TEMP SMIN = TEMP SET.
13. A system according to claim 1, wherein each energy emitter defines an energy emitting zone E(J);
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), AMP E(J) being set to be essentially the same for all E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E(J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for identifying the lowest read temperature condition TEMP SMIN of all TEMP(J) and means for comparing the lowest read temperature condition TEMP SMIN to the predetermined temperature condition, designated TEMP SET, and the signal is based upon the comparison; and the temperature controller varies the power pulse to each zone E(J) based upon the signal by varying AMP E(J) for all E(J) to maintain TEMP SMIN = TEMP SET while also varying the DUTYCYCLE E(J) of each zone E(J) where TEMP(J) > TEMP SMIN to maintain TEMP(J) = TEMP SET for each such zone.
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), AMP E(J) being set to be essentially the same for all E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E(J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for identifying the lowest read temperature condition TEMP SMIN of all TEMP(J) and means for comparing the lowest read temperature condition TEMP SMIN to the predetermined temperature condition, designated TEMP SET, and the signal is based upon the comparison; and the temperature controller varies the power pulse to each zone E(J) based upon the signal by varying AMP E(J) for all E(J) to maintain TEMP SMIN = TEMP SET while also varying the DUTYCYCLE E(J) of each zone E(J) where TEMP(J) > TEMP SMIN to maintain TEMP(J) = TEMP SET for each such zone.
14. A system according to claim 1, wherein the selected one of the measured temperatures comprises the highest one of the measured temperatures.
15. A system according to claim 1, wherein the power controller individually couples each energy emitter to the source of ablating energy to convey ablating energy individually to each energy emitter in a sequence of power pulses, each power pulse having a duty cycle and an amplitude, wherein power delivered to each energy emitter for ablating tissue is expressed as follows:
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE; and the temperature controller varies the power pulses to the energy emitters based upon the signal.
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE; and the temperature controller varies the power pulses to the energy emitters based upon the signal.
16. A system according to claim 1, wherein each energy emitter defines an energy emitting zone E(J);
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E(J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for comparing each read temperature condition TEMP(J) to a prescribed low threshold temperature condition TEMP LOWTHRESH and a prescribed high threshold temperature condition TEMP HITHRESH; and the temperature controller turns off a given zone E(J) when TEMP(J) for that zone >= TEMP HITHRESH and turns on the given zone E(J) when TEMP(J) for that zone < TEMP LOWTHRESH.
the temperature measured at each energy emitting zone E(J) is designated TEMP(J);
the power controller includes a switching element to individually convey ablating energy to each zone E(J) in a power pulse having a duty cycle DUTYCYCLE E(J) and an amplitude AMP E(J), wherein the power P E(J) delivered to each zone E(J) is expressed as follows:
P E(J) .apprxeq. AMP E(J)2 × DUTYCYCLE E(J);
the processing element includes means for comparing each read temperature condition TEMP(J) to a prescribed low threshold temperature condition TEMP LOWTHRESH and a prescribed high threshold temperature condition TEMP HITHRESH; and the temperature controller turns off a given zone E(J) when TEMP(J) for that zone >= TEMP HITHRESH and turns on the given zone E(J) when TEMP(J) for that zone < TEMP LOWTHRESH.
17. A system according to claim 1, wherein there are at least two temperature sensing elements at each energy emitter for measuring temperature at the energy emitter;
the processing element periodically reads the temperatures measured by each of the temperature sensing elements for each energy emitter and selects for each energy emitter the hottest one of the measured temperatures, compares the hottest one of the temperatures for each energy emitter to the predetermined temperature, and generates a signal individually for each energy emitter based upon the comparison, and the temperature controller individually controls the conveyance of energy to each energy emitter based upon the signal for that energy emitter to maintain the hottest temperature at all energy emitters essentially at the predetermined temperature.
the processing element periodically reads the temperatures measured by each of the temperature sensing elements for each energy emitter and selects for each energy emitter the hottest one of the measured temperatures, compares the hottest one of the temperatures for each energy emitter to the predetermined temperature, and generates a signal individually for each energy emitter based upon the comparison, and the temperature controller individually controls the conveyance of energy to each energy emitter based upon the signal for that energy emitter to maintain the hottest temperature at all energy emitters essentially at the predetermined temperature.
18. A system according to claim 17, wherein the power controller individually couples each energy emitter to the source of ablating energy to convey ablating energy individually to each energy emitter in a sequence of power pulses, each power pulse having a duty cycle and an amplitude, wherein power delivered to each energy emitter for ablating tissue is expressed as follows:
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the hottest temperature at all energy emitters essentially at the predetermined temperature.
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the hottest temperature at all energy emitters essentially at the predetermined temperature.
19. A system according to claim 1, wherein there are at least two temperature sensing elements at each energy emitter for measuring temperature at the energy emitter;
the power controller individually couples each energy emitter to the source of ablating energy to convey ablating energy individually to each energy emitter in a sequence of power pulses, each power pulse having a duty cycle and an amplitude, wherein power delivered to each energy emitter for ablating tissue is expressed as follows:
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE;
the processing element periodically reads the temperatures measured by each of the temperature sensing elements for each energy emitter, predicts for each energy emitter the hottest tissue temperature, compares the predicted hottest temperature for each energy emitter to the predetermined temperature, and generates a signal individually for each energy emitter based upon the comparison; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the predicted hottest temperature at all energy emitters essentially at the predetermined temperature.
the power controller individually couples each energy emitter to the source of ablating energy to convey ablating energy individually to each energy emitter in a sequence of power pulses, each power pulse having a duty cycle and an amplitude, wherein power delivered to each energy emitter for ablating tissue is expressed as follows:
POWER .apprxeq. AMPLITUDE2 × DUTYCYCLE;
the processing element periodically reads the temperatures measured by each of the temperature sensing elements for each energy emitter, predicts for each energy emitter the hottest tissue temperature, compares the predicted hottest temperature for each energy emitter to the predetermined temperature, and generates a signal individually for each energy emitter based upon the comparison; and the temperature controller individually varies the power pulse to each energy emitter based upon the signal for that energy emitter to maintain the predicted hottest temperature at all energy emitters essentially at the predetermined temperature.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26693494A | 1994-06-27 | 1994-06-27 | |
US08/266,934 | 1994-06-27 | ||
US28693094A | 1994-08-08 | 1994-08-08 | |
US08/286,930 | 1994-08-08 | ||
PCT/US1994/011748 WO1996000036A1 (en) | 1994-06-27 | 1994-10-14 | System for controlling tissue ablation using temperature sensors |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2194062A1 CA2194062A1 (en) | 1996-01-04 |
CA2194062C true CA2194062C (en) | 2005-06-28 |
Family
ID=26952123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002194062A Expired - Fee Related CA2194062C (en) | 1994-06-27 | 1994-10-14 | System for controlling tissue ablation using temperature sensors |
Country Status (8)
Country | Link |
---|---|
US (1) | US5769847A (en) |
EP (1) | EP0768841B1 (en) |
JP (2) | JP3564141B2 (en) |
AT (1) | ATE255369T1 (en) |
CA (1) | CA2194062C (en) |
DE (1) | DE69433387T2 (en) |
ES (1) | ES2214493T3 (en) |
WO (1) | WO1996000036A1 (en) |
Families Citing this family (321)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US6142992A (en) | 1993-05-10 | 2000-11-07 | Arthrocare Corporation | Power supply for limiting power in electrosurgery |
US6355032B1 (en) | 1995-06-07 | 2002-03-12 | Arthrocare Corporation | Systems and methods for selective electrosurgical treatment of body structures |
US6024733A (en) * | 1995-06-07 | 2000-02-15 | Arthrocare Corporation | System and method for epidermal tissue ablation |
US5766153A (en) | 1993-05-10 | 1998-06-16 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
US6391025B1 (en) | 1993-05-10 | 2002-05-21 | Arthrocare Corporation | Electrosurgical scalpel and methods for tissue cutting |
US6235020B1 (en) | 1993-05-10 | 2001-05-22 | Arthrocare Corporation | Power supply and methods for fluid delivery in electrosurgery |
CA2194061C (en) * | 1994-06-27 | 2006-04-11 | David K. Swanson | Systems and methods for sensing temperature within the body |
ES2214493T3 (en) † | 1994-06-27 | 2004-09-16 | Boston Scientific Limited | A TISSUE ABLATION REGULATION SYSTEM USING THE TEMPERATURE SENSORS. |
US5810802A (en) | 1994-08-08 | 1998-09-22 | E.P. Technologies, Inc. | Systems and methods for controlling tissue ablation using multiple temperature sensing elements |
EP0957792A4 (en) * | 1995-05-02 | 2000-09-20 | Heart Rhythm Tech Inc | System for controlling the energy delivered to a patient for ablation |
US6149620A (en) | 1995-11-22 | 2000-11-21 | Arthrocare Corporation | System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid |
US7758537B1 (en) | 1995-11-22 | 2010-07-20 | Arthrocare Corporation | Systems and methods for electrosurgical removal of the stratum corneum |
US7270661B2 (en) * | 1995-11-22 | 2007-09-18 | Arthocare Corporation | Electrosurgical apparatus and methods for treatment and removal of tissue |
US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
US6180867B1 (en) * | 1996-04-17 | 2001-01-30 | General Electric Company | Thermal sensor array and methods of fabrication and use |
US5987360A (en) * | 1996-05-03 | 1999-11-16 | Urologix, Inc. | Axial preferential thermal therapy |
US6066139A (en) * | 1996-05-14 | 2000-05-23 | Sherwood Services Ag | Apparatus and method for sterilization and embolization |
US6620155B2 (en) | 1996-07-16 | 2003-09-16 | Arthrocare Corp. | System and methods for electrosurgical tissue contraction within the spine |
US5893885A (en) * | 1996-11-01 | 1999-04-13 | Cordis Webster, Inc. | Multi-electrode ablation catheter |
US5954719A (en) * | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US5916213A (en) * | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
US6652515B1 (en) * | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6139546A (en) * | 1997-10-06 | 2000-10-31 | Somnus Medical Technologies, Inc. | Linear power control with digital phase lock |
DE19757720A1 (en) | 1997-12-23 | 1999-06-24 | Sulzer Osypka Gmbh | Method for operating a high-frequency ablation device and device for high-frequency tissue ablation |
US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
US6440127B2 (en) | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
US6447505B2 (en) | 1998-02-11 | 2002-09-10 | Cosman Company, Inc. | Balloon catheter method for intra-urethral radio-frequency urethral enlargement |
US6355031B1 (en) | 1998-02-19 | 2002-03-12 | Curon Medical, Inc. | Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter |
DE19817553A1 (en) * | 1998-04-15 | 1999-10-21 | Biotronik Mess & Therapieg | Ablation arrangement |
US6059778A (en) | 1998-05-05 | 2000-05-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using unipolar and bipolar techniques |
US6042580A (en) * | 1998-05-05 | 2000-03-28 | Cardiac Pacemakers, Inc. | Electrode having composition-matched, common-lead thermocouple wire for providing multiple temperature-sensitive junctions |
US6558378B2 (en) | 1998-05-05 | 2003-05-06 | Cardiac Pacemakers, Inc. | RF ablation system and method having automatic temperature control |
US6312425B1 (en) | 1998-05-05 | 2001-11-06 | Cardiac Pacemakers, Inc. | RF ablation catheter tip electrode with multiple thermal sensors |
US6251107B1 (en) * | 1998-06-25 | 2001-06-26 | Cardima, Inc. | Ep catheter |
US7276063B2 (en) | 1998-08-11 | 2007-10-02 | Arthrocare Corporation | Instrument for electrosurgical tissue treatment |
WO2000015130A2 (en) * | 1998-09-10 | 2000-03-23 | Scimed Life Systems, Inc. | Systems for controlling an ablation process performed with a heart electrocatheter |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6245065B1 (en) | 1998-09-10 | 2001-06-12 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6183468B1 (en) | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US7364577B2 (en) | 2002-02-11 | 2008-04-29 | Sherwood Services Ag | Vessel sealing system |
US7901400B2 (en) * | 1998-10-23 | 2011-03-08 | Covidien Ag | Method and system for controlling output of RF medical generator |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
US7194294B2 (en) | 1999-01-06 | 2007-03-20 | Scimed Life Systems, Inc. | Multi-functional medical catheter and methods of use |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US6290699B1 (en) * | 1999-07-07 | 2001-09-18 | Uab Research Foundation | Ablation tool for forming lesions in body tissue |
US6315732B1 (en) | 1999-07-20 | 2001-11-13 | Scimed Life Systems, Inc. | Imaging catheter and methods of use for ultrasound-guided ablation |
US6517538B1 (en) * | 1999-10-15 | 2003-02-11 | Harold Jacob | Temperature-controlled snare |
US6542781B1 (en) | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6613046B1 (en) | 1999-11-22 | 2003-09-02 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
WO2001037723A2 (en) * | 1999-11-22 | 2001-05-31 | Boston Scientific Limited | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
ES2245496T3 (en) * | 1999-12-29 | 2006-01-01 | Rudiger Stockert | DEVICE FOR THE TREATMENT OF BIOLOGICAL FABRIC THROUGH HIGH FREQUENCY CURRENT. |
WO2001082812A1 (en) * | 2000-04-27 | 2001-11-08 | Medtronic, Inc. | Vibration sensitive ablation apparatus and method |
WO2001082811A1 (en) | 2000-04-27 | 2001-11-08 | Medtronic, Inc. | System and method for assessing transmurality of ablation lesions |
EP1280467B8 (en) * | 2000-05-12 | 2009-11-18 | Cardima, Inc. | Multi-channel rf energy delivery with coagulum reduction |
DE60109444T2 (en) | 2000-06-13 | 2006-04-13 | Atrionix, Inc., Irwindale | SURGICAL ABLATION PROBE FOR FORMING A RINGED LESION |
US6511478B1 (en) * | 2000-06-30 | 2003-01-28 | Scimed Life Systems, Inc. | Medical probe with reduced number of temperature sensor wires |
US6425894B1 (en) * | 2000-07-12 | 2002-07-30 | Biosense Webster, Inc. | Ablation catheter with electrode temperature monitoring |
US6746446B1 (en) * | 2000-08-04 | 2004-06-08 | Cardima, Inc. | Electrophysiological device for the isthmus |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US6752804B2 (en) | 2000-12-28 | 2004-06-22 | Cardiac Pacemakers, Inc. | Ablation system and method having multiple-sensor electrodes to assist in assessment of electrode and sensor position and adjustment of energy levels |
US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
US6692492B2 (en) * | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
US7361830B2 (en) * | 2002-03-21 | 2008-04-22 | Rtd Company | Polymer encapsulated micro-thermocouple |
US20140018880A1 (en) | 2002-04-08 | 2014-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
ATE371413T1 (en) | 2002-05-06 | 2007-09-15 | Covidien Ag | BLOOD DETECTOR FOR CHECKING AN ELECTROSURGICAL UNIT |
US6893442B2 (en) * | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US9439714B2 (en) * | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US7063698B2 (en) * | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7572257B2 (en) | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US8235990B2 (en) | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US6887237B2 (en) * | 2002-07-22 | 2005-05-03 | Medtronic, Inc. | Method for treating tissue with a wet electrode and apparatus for using same |
US7044948B2 (en) | 2002-12-10 | 2006-05-16 | Sherwood Services Ag | Circuit for controlling arc energy from an electrosurgical generator |
US7104985B2 (en) * | 2003-03-06 | 2006-09-12 | Martinelli Michael A | Apparatus and method for causing selective necrosis of abnormal cells |
EP1617776B1 (en) | 2003-05-01 | 2015-09-02 | Covidien AG | System for programing and controlling an electrosurgical generator system |
EP1651127B1 (en) | 2003-07-16 | 2012-10-31 | Arthrocare Corporation | Rotary electrosurgical apparatus |
EP2452648B1 (en) | 2003-09-12 | 2016-02-10 | Vessix Vascular, Inc. | System for selectable eccentric remodeling and/or ablation of atherosclerotic material |
WO2005050151A1 (en) | 2003-10-23 | 2005-06-02 | Sherwood Services Ag | Thermocouple measurement circuit |
EP1675499B1 (en) | 2003-10-23 | 2011-10-19 | Covidien AG | Redundant temperature monitoring in electrosurgical systems for safety mitigation |
US7396336B2 (en) | 2003-10-30 | 2008-07-08 | Sherwood Services Ag | Switched resonant ultrasonic power amplifier system |
US7131860B2 (en) | 2003-11-20 | 2006-11-07 | Sherwood Services Ag | Connector systems for electrosurgical generator |
US7300435B2 (en) * | 2003-11-21 | 2007-11-27 | Sherwood Services Ag | Automatic control system for an electrosurgical generator |
US7766905B2 (en) | 2004-02-12 | 2010-08-03 | Covidien Ag | Method and system for continuity testing of medical electrodes |
US7780662B2 (en) | 2004-03-02 | 2010-08-24 | Covidien Ag | Vessel sealing system using capacitive RF dielectric heating |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US7628786B2 (en) | 2004-10-13 | 2009-12-08 | Covidien Ag | Universal foot switch contact port |
US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
US20090240249A1 (en) * | 2004-11-08 | 2009-09-24 | Cardima, Inc. | System and Method for Performing Ablation and Other Medical Procedures Using An Electrode Array with Flexible Circuit |
US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
US7429261B2 (en) | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
US7468062B2 (en) | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
DE102005007769B4 (en) * | 2005-02-19 | 2008-09-04 | Bowa-Electronic Gmbh | High frequency surgery device and method of operation therefor |
US8182433B2 (en) * | 2005-03-04 | 2012-05-22 | Endosense Sa | Medical apparatus system having optical fiber load sensing capability |
WO2006092021A1 (en) * | 2005-03-04 | 2006-09-08 | Intervention Technology Pty Ltd | A minimal device and method for effecting hyperthermia derived anaesthesia |
US8075498B2 (en) | 2005-03-04 | 2011-12-13 | Endosense Sa | Medical apparatus system having optical fiber load sensing capability |
US7236567B2 (en) * | 2005-03-24 | 2007-06-26 | Siemens Aktiengesellschaft | Method and apparatus for synchronizing operation of an x-ray system and a magnetic system |
US9474564B2 (en) | 2005-03-31 | 2016-10-25 | Covidien Ag | Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
AU2006262447A1 (en) | 2005-06-20 | 2007-01-04 | Medtronic Ablation Frontiers Llc | Ablation catheter |
US7655003B2 (en) | 2005-06-22 | 2010-02-02 | Smith & Nephew, Inc. | Electrosurgical power control |
AU2006268238A1 (en) * | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
EP3028645B1 (en) | 2005-08-01 | 2019-09-18 | St. Jude Medical International Holding S.à r.l. | Medical apparatus system having optical fiber load sensing capability |
US7719400B1 (en) * | 2005-08-02 | 2010-05-18 | Rtd Company | Method and apparatus for flexible temperature sensor having coiled element |
US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
US8734438B2 (en) | 2005-10-21 | 2014-05-27 | Covidien Ag | Circuit and method for reducing stored energy in an electrosurgical generator |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US7947039B2 (en) | 2005-12-12 | 2011-05-24 | Covidien Ag | Laparoscopic apparatus for performing electrosurgical procedures |
US8876746B2 (en) | 2006-01-06 | 2014-11-04 | Arthrocare Corporation | Electrosurgical system and method for treating chronic wound tissue |
US7691101B2 (en) | 2006-01-06 | 2010-04-06 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
BRPI0706605B8 (en) | 2006-01-17 | 2021-06-22 | Endymed Medical Ltd | electrosurgical system employing phase-controlled radiofrequency energy |
CA2574935A1 (en) | 2006-01-24 | 2007-07-24 | Sherwood Services Ag | A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm |
US8216223B2 (en) | 2006-01-24 | 2012-07-10 | Covidien Ag | System and method for tissue sealing |
US8147485B2 (en) | 2006-01-24 | 2012-04-03 | Covidien Ag | System and method for tissue sealing |
US7972328B2 (en) | 2006-01-24 | 2011-07-05 | Covidien Ag | System and method for tissue sealing |
CA2574934C (en) | 2006-01-24 | 2015-12-29 | Sherwood Services Ag | System and method for closed loop monitoring of monopolar electrosurgical apparatus |
US8685016B2 (en) | 2006-01-24 | 2014-04-01 | Covidien Ag | System and method for tissue sealing |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
US9186200B2 (en) | 2006-01-24 | 2015-11-17 | Covidien Ag | System and method for tissue sealing |
US7651493B2 (en) | 2006-03-03 | 2010-01-26 | Covidien Ag | System and method for controlling electrosurgical snares |
US7648499B2 (en) | 2006-03-21 | 2010-01-19 | Covidien Ag | System and method for generating radio frequency energy |
US7651492B2 (en) | 2006-04-24 | 2010-01-26 | Covidien Ag | Arc based adaptive control system for an electrosurgical unit |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US8753334B2 (en) | 2006-05-10 | 2014-06-17 | Covidien Ag | System and method for reducing leakage current in an electrosurgical generator |
EP2020943B1 (en) | 2006-05-30 | 2015-07-08 | ArthroCare Corporation | Hard tissue ablation system |
US8567265B2 (en) | 2006-06-09 | 2013-10-29 | Endosense, SA | Triaxial fiber optic force sensing catheter |
US8048063B2 (en) * | 2006-06-09 | 2011-11-01 | Endosense Sa | Catheter having tri-axial force sensor |
ES2928065T3 (en) | 2006-06-28 | 2022-11-15 | Medtronic Ardian Luxembourg | Thermally induced renal neuromodulation systems |
US7731717B2 (en) | 2006-08-08 | 2010-06-08 | Covidien Ag | System and method for controlling RF output during tissue sealing |
US8034049B2 (en) | 2006-08-08 | 2011-10-11 | Covidien Ag | System and method for measuring initial tissue impedance |
US7794457B2 (en) | 2006-09-28 | 2010-09-14 | Covidien Ag | Transformer for RF voltage sensing |
WO2008049082A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | Inducing desirable temperature effects on body tissue |
CA2666661C (en) | 2006-10-18 | 2015-01-20 | Minnow Medical, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
WO2008049087A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
WO2008057118A1 (en) | 2006-11-09 | 2008-05-15 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
GB2452103B (en) | 2007-01-05 | 2011-08-31 | Arthrocare Corp | Electrosurgical system with suction control apparatus and system |
WO2008125962A2 (en) * | 2007-03-01 | 2008-10-23 | Endymed Medical Ltd. | Electrosurgical methods and devices employing semiconductor chips |
US7862560B2 (en) | 2007-03-23 | 2011-01-04 | Arthrocare Corporation | Ablation apparatus having reduced nerve stimulation and related methods |
US8777941B2 (en) | 2007-05-10 | 2014-07-15 | Covidien Lp | Adjustable impedance electrosurgical electrodes |
US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
US8157789B2 (en) * | 2007-05-24 | 2012-04-17 | Endosense Sa | Touch sensing catheter |
US8622935B1 (en) | 2007-05-25 | 2014-01-07 | Endosense Sa | Elongated surgical manipulator with body position and distal force sensing |
US7834484B2 (en) | 2007-07-16 | 2010-11-16 | Tyco Healthcare Group Lp | Connection cable and method for activating a voltage-controlled generator |
US8216220B2 (en) | 2007-09-07 | 2012-07-10 | Tyco Healthcare Group Lp | System and method for transmission of combined data stream |
US8512332B2 (en) | 2007-09-21 | 2013-08-20 | Covidien Lp | Real-time arc control in electrosurgical generators |
EP2209517A4 (en) | 2007-10-05 | 2011-03-30 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US9008793B1 (en) * | 2007-10-15 | 2015-04-14 | Chenes Llc | Multiple electrode radiofrequency generator |
JP5587786B2 (en) | 2007-12-06 | 2014-09-10 | コーニンクレッカ フィリップス エヌ ヴェ | Apparatus, method and computer program for applying energy to object |
US9358063B2 (en) | 2008-02-14 | 2016-06-07 | Arthrocare Corporation | Ablation performance indicator for electrosurgical devices |
ES2701878T3 (en) * | 2008-03-18 | 2019-02-26 | Circa Scient Llc | Temperature sensing device in large surface area |
US20090272905A1 (en) * | 2008-05-05 | 2009-11-05 | Roderick Bernhard Richards | Wireless x-ray detector plate |
US8298227B2 (en) * | 2008-05-14 | 2012-10-30 | Endosense Sa | Temperature compensated strain sensing catheter |
US8226639B2 (en) | 2008-06-10 | 2012-07-24 | Tyco Healthcare Group Lp | System and method for output control of electrosurgical generator |
US8747400B2 (en) | 2008-08-13 | 2014-06-10 | Arthrocare Corporation | Systems and methods for screen electrode securement |
US8364279B2 (en) | 2008-09-25 | 2013-01-29 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads having RF compatibility and methods of use and manufacture |
US8133219B2 (en) | 2008-10-07 | 2012-03-13 | Olympus Medical Systems Corp. | High frequency operation apparatus and high frequency operation method |
WO2010055455A1 (en) * | 2008-11-11 | 2010-05-20 | Koninklijke Philips Electronics N.V. | Medical device comprising a probe for measuring temperature data in a patient's tissue |
WO2010056745A1 (en) | 2008-11-17 | 2010-05-20 | Minnow Medical, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8355799B2 (en) | 2008-12-12 | 2013-01-15 | Arthrocare Corporation | Systems and methods for limiting joint temperature |
US8262652B2 (en) | 2009-01-12 | 2012-09-11 | Tyco Healthcare Group Lp | Imaginary impedance process monitoring and intelligent shut-off |
US8574187B2 (en) | 2009-03-09 | 2013-11-05 | Arthrocare Corporation | System and method of an electrosurgical controller with output RF energy control |
US8430875B2 (en) | 2009-05-19 | 2013-04-30 | Estech, Inc. (Endoscopic Technologies, Inc.) | Magnetic navigation systems and methods |
US8257350B2 (en) | 2009-06-17 | 2012-09-04 | Arthrocare Corporation | Method and system of an electrosurgical controller with wave-shaping |
US20110026562A1 (en) * | 2009-07-31 | 2011-02-03 | Rtd Company | Temperature sensor using thin film resistance temperature detector |
US9775664B2 (en) | 2009-09-22 | 2017-10-03 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US20110112529A1 (en) | 2009-09-22 | 2011-05-12 | Mederi Therapeutics Inc. | Systems and methods for controlling use and operation of a family of different treatment devices |
US10386990B2 (en) | 2009-09-22 | 2019-08-20 | Mederi Rf, Llc | Systems and methods for treating tissue with radiofrequency energy |
US9474565B2 (en) | 2009-09-22 | 2016-10-25 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US9750563B2 (en) | 2009-09-22 | 2017-09-05 | Mederi Therapeutics, Inc. | Systems and methods for treating tissue with radiofrequency energy |
US8323279B2 (en) | 2009-09-25 | 2012-12-04 | Arthocare Corporation | System, method and apparatus for electrosurgical instrument with movable fluid delivery sheath |
US8317786B2 (en) | 2009-09-25 | 2012-11-27 | AthroCare Corporation | System, method and apparatus for electrosurgical instrument with movable suction sheath |
US20110118731A1 (en) * | 2009-11-16 | 2011-05-19 | Tyco Healthcare Group Lp | Multi-Phase Electrode |
US8372067B2 (en) | 2009-12-09 | 2013-02-12 | Arthrocare Corporation | Electrosurgery irrigation primer systems and methods |
US8668686B2 (en) * | 2009-12-23 | 2014-03-11 | Biosense Webster (Israel) Ltd. | Sensing contact of ablation catheter using differential temperature measurements |
US20110172659A1 (en) * | 2010-01-13 | 2011-07-14 | Vivant Medical, Inc. | Ablation Device With User Interface at Device Handle, System Including Same, and Method of Ablating Tissue Using Same |
US20110208180A1 (en) * | 2010-02-25 | 2011-08-25 | Vivant Medical, Inc. | System and Method for Monitoring Ablation Size |
US8556891B2 (en) * | 2010-03-03 | 2013-10-15 | Medtronic Ablation Frontiers Llc | Variable-output radiofrequency ablation power supply |
US8747399B2 (en) | 2010-04-06 | 2014-06-10 | Arthrocare Corporation | Method and system of reduction of low frequency muscle stimulation during electrosurgical procedures |
JP2013523318A (en) | 2010-04-09 | 2013-06-17 | べシックス・バスキュラー・インコーポレイテッド | Power generation and control equipment for tissue treatment |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8696659B2 (en) | 2010-04-30 | 2014-04-15 | Arthrocare Corporation | Electrosurgical system and method having enhanced temperature measurement |
EP2568902A1 (en) * | 2010-05-10 | 2013-03-20 | Medtronic, Inc. | System for selecting an ablation procedure based on comparing a biological response with a mathematical model |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US8685018B2 (en) | 2010-10-15 | 2014-04-01 | Arthrocare Corporation | Electrosurgical wand and related method and system |
US8568405B2 (en) | 2010-10-15 | 2013-10-29 | Arthrocare Corporation | Electrosurgical wand and related method and system |
USD658760S1 (en) | 2010-10-15 | 2012-05-01 | Arthrocare Corporation | Wound care electrosurgical wand |
US9066720B2 (en) | 2010-10-25 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
EP2632378B1 (en) | 2010-10-25 | 2018-10-17 | Medtronic Ardian Luxembourg S.à.r.l. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9737353B2 (en) | 2010-12-16 | 2017-08-22 | Biosense Webster (Israel) Ltd. | System for controlling tissue ablation using temperature sensors |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9131597B2 (en) | 2011-02-02 | 2015-09-08 | Arthrocare Corporation | Electrosurgical system and method for treating hard body tissue |
US10561368B2 (en) | 2011-04-14 | 2020-02-18 | St. Jude Medical International Holding S.À R.L. | Compact force sensor for catheters |
US10959775B2 (en) | 2011-06-06 | 2021-03-30 | Cosman Instruments, Llc | Cool RF electrode |
US10639101B2 (en) | 2011-06-06 | 2020-05-05 | Cosman Instruments, Llc | Cool RF electrode |
WO2013013156A2 (en) | 2011-07-20 | 2013-01-24 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
EP2734264B1 (en) | 2011-07-22 | 2018-11-21 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US9247985B2 (en) * | 2011-07-27 | 2016-02-02 | Biosense Webster (Israel) Ltd. | Test jig for ablator |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
AU2012358143B2 (en) | 2011-12-23 | 2015-06-11 | Boston Scientific Scimed, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10076383B2 (en) | 2012-01-25 | 2018-09-18 | Covidien Lp | Electrosurgical device having a multiplexer |
US9192308B2 (en) * | 2012-03-27 | 2015-11-24 | Covidien Lp | Microwave-shielded tissue sensor probe |
KR101942027B1 (en) * | 2012-03-28 | 2019-04-11 | 삼성전자 주식회사 | Method for predicting temperature in device |
US9179972B2 (en) | 2012-05-04 | 2015-11-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for controlling delivery of ablation energy to tissue |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
MX2014013323A (en) | 2012-05-11 | 2015-01-22 | Medtronic Ardian Luxembourg | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods. |
US9770293B2 (en) | 2012-06-04 | 2017-09-26 | Boston Scientific Scimed, Inc. | Systems and methods for treating tissue of a passageway within a body |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
US20140064334A1 (en) * | 2012-09-06 | 2014-03-06 | General Electric Company | Measurement rake with a two piece cylindrical mast |
WO2014043687A2 (en) | 2012-09-17 | 2014-03-20 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
WO2014047454A2 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
JP6074051B2 (en) | 2012-10-10 | 2017-02-01 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Intravascular neuromodulation system and medical device |
US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
US9713489B2 (en) | 2013-03-07 | 2017-07-25 | Arthrocare Corporation | Electrosurgical methods and systems |
US9693818B2 (en) | 2013-03-07 | 2017-07-04 | Arthrocare Corporation | Methods and systems related to electrosurgical wands |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9801678B2 (en) | 2013-03-13 | 2017-10-31 | Arthrocare Corporation | Method and system of controlling conductive fluid flow during an electrosurgical procedure |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
WO2014150471A1 (en) * | 2013-03-15 | 2014-09-25 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
EP2967703B1 (en) * | 2013-03-15 | 2018-03-07 | St. Jude Medical, Cardiology Division, Inc. | Multi-electrode ablation system with a controller for determining a thermal gain of each electrode |
JP2016524949A (en) | 2013-06-21 | 2016-08-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation having a rotatable shaft |
EP3010437A1 (en) | 2013-06-21 | 2016-04-27 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
AU2014284558B2 (en) | 2013-07-01 | 2017-08-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
EP3049007B1 (en) | 2013-07-19 | 2019-06-12 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
CN103330578B (en) * | 2013-07-19 | 2015-05-27 | 乐普(北京)医疗器械股份有限公司 | Approximate-circumference type ultrasonic ablation catheter |
JP6122217B2 (en) | 2013-07-22 | 2017-04-26 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal nerve ablation medical device |
WO2015013205A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9872719B2 (en) | 2013-07-24 | 2018-01-23 | Covidien Lp | Systems and methods for generating electrosurgical energy using a multistage power converter |
US9636165B2 (en) | 2013-07-29 | 2017-05-02 | Covidien Lp | Systems and methods for measuring tissue impedance through an electrosurgical cable |
CN105338917B (en) | 2013-08-02 | 2018-02-06 | 奥林巴斯株式会社 | Bio-tissue mating system, treatment apparatus control device |
CN105473093B (en) | 2013-08-22 | 2019-02-05 | 波士顿科学国际有限公司 | Flexible circuit with the improved adhesion strength to renal nerve modulation sacculus |
CN105555218B (en) | 2013-09-04 | 2019-01-15 | 波士顿科学国际有限公司 | With radio frequency (RF) foley's tube rinsed with cooling capacity |
US20150073515A1 (en) | 2013-09-09 | 2015-03-12 | Medtronic Ardian Luxembourg S.a.r.I. | Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods |
EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
WO2015057584A1 (en) | 2013-10-15 | 2015-04-23 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
WO2015057961A1 (en) | 2013-10-18 | 2015-04-23 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
WO2015061457A1 (en) | 2013-10-25 | 2015-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
EP3062695B1 (en) | 2013-10-31 | 2020-12-02 | Boston Scientific Scimed, Inc. | Medical device for high resolution mapping using localized matching |
CN105636514B (en) | 2013-11-01 | 2020-06-05 | 波士顿科学医学有限公司 | Cardiac mapping using delay interpolation |
US11096736B2 (en) * | 2013-12-09 | 2021-08-24 | Biosense Webster (Israel) Ltd. | Pericardial catheter with temperature sensing array |
WO2015103617A1 (en) | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
EP3102136B1 (en) | 2014-02-04 | 2018-06-27 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US10130413B2 (en) * | 2014-02-11 | 2018-11-20 | Covidien Lp | Temperature-sensing electrically-conductive tissue-contacting plate and methods of manufacturing same |
US9526556B2 (en) | 2014-02-28 | 2016-12-27 | Arthrocare Corporation | Systems and methods systems related to electrosurgical wands with screen electrodes |
CN106061372A (en) | 2014-03-07 | 2016-10-26 | 波士顿科学医学有限公司 | Medical devices for mapping cardiac tissue |
WO2015138167A1 (en) | 2014-03-11 | 2015-09-17 | Boston Scientific Scimed, Inc. | Medical devices for mapping cardiac tissue |
US9956035B2 (en) | 2014-03-27 | 2018-05-01 | Biosense Webster (Israel) Ltd. | Temperature measurement in catheter |
US20150300888A1 (en) * | 2014-04-21 | 2015-10-22 | National Taiwan University | Temperature prediction system and method thereof |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
US10136943B1 (en) | 2014-10-21 | 2018-11-27 | Cosman Instruments, Llc | Electrosurgical system |
US9717552B2 (en) | 2014-05-06 | 2017-08-01 | Cosman Intruments, Llc | Electrosurgical generator |
US20150342671A1 (en) | 2014-05-29 | 2015-12-03 | Biosense Webster (Israel) Ltd. | Catheter electrode with multiple thermocouples |
JP2016007333A (en) * | 2014-06-24 | 2016-01-18 | 株式会社グッドマン | Electrode member for ablation and catheter for ablation |
US9649148B2 (en) | 2014-07-24 | 2017-05-16 | Arthrocare Corporation | Electrosurgical system and method having enhanced arc prevention |
US9597142B2 (en) | 2014-07-24 | 2017-03-21 | Arthrocare Corporation | Method and system related to electrosurgical procedures |
US10194971B2 (en) | 2014-09-26 | 2019-02-05 | Cosman Medical, Inc. | Electrosurgical generator |
WO2016081611A1 (en) | 2014-11-19 | 2016-05-26 | Advanced Cardiac Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
CA2967829A1 (en) | 2014-11-19 | 2016-05-26 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
EP3220843B1 (en) * | 2014-11-19 | 2020-01-01 | EPiX Therapeutics, Inc. | Ablation devices and methods of using a high-resolution electrode assembly |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
WO2016161209A1 (en) * | 2015-03-31 | 2016-10-06 | St. Jude Medical, Cardiology Division, Inc. | Methods and devices for delivering pulsed rf energy during catheter ablation |
US10285754B2 (en) * | 2015-05-18 | 2019-05-14 | Biosense Webster (Israel) Ltd. | Catheter with coaxial thermocouple |
US10285752B2 (en) * | 2015-12-07 | 2019-05-14 | Biosense Webster (Israel) Ltd. | Multilayer split ablation electrode |
EP3677206B1 (en) | 2016-01-07 | 2022-02-23 | St. Jude Medical International Holding S.à r.l. | Medical device with multi-core fiber for optical sensing |
KR20180124070A (en) | 2016-03-15 | 2018-11-20 | 에픽스 테라퓨틱스, 인크. | Improved apparatus, systems and methods for irrigation ablation |
US10751118B2 (en) | 2016-03-21 | 2020-08-25 | St. Jude Medical, Cardiology Division, Inc. | Multiple thermocouple assembly with reduced wire count |
US10933250B2 (en) | 2016-04-22 | 2021-03-02 | Syneron Medical Ltd. | Skin treatment apparatus and method |
US11484711B2 (en) | 2016-07-26 | 2022-11-01 | The Cleveland Clinic Foundation | Stereo-thermo-lesioning to treat a patient's neurological condition |
CN109788982B (en) | 2016-10-04 | 2021-11-02 | 圣犹达医疗用品心脏病学部门有限公司 | Ablation catheter tip |
JP6866110B2 (en) * | 2016-10-31 | 2021-04-28 | 日本ライフライン株式会社 | Catheter for measuring esophageal temperature |
EP3614946B1 (en) | 2017-04-27 | 2024-03-20 | EPiX Therapeutics, Inc. | Determining nature of contact between catheter tip and tissue |
CA3061710A1 (en) | 2017-04-28 | 2018-11-01 | Stryker Corporation | Control console and accessories for rf nerve ablation and methods of operating the same |
US20210045805A1 (en) * | 2019-08-15 | 2021-02-18 | Biosense Webster (Israel) Ltd. | Dynamic ablation and sensing according to contact of segmented electrodes |
US11253720B2 (en) | 2020-02-29 | 2022-02-22 | Cutera, Inc. | Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing |
US10864380B1 (en) | 2020-02-29 | 2020-12-15 | Cutera, Inc. | Systems and methods for controlling therapeutic laser pulse duration |
CN111728691B (en) * | 2020-07-07 | 2022-12-27 | 昆山雷盛医疗科技有限公司 | Catheter-type thermal ablation therapeutic apparatus and contact condition detection method thereof |
CN117500449A (en) * | 2021-06-16 | 2024-02-02 | 柯惠有限合伙公司 | Surgical systems and methods for predicting and/or controlling thermal spread using temperature |
CN115177361A (en) * | 2022-08-18 | 2022-10-14 | 上海美杰医疗科技有限公司 | Temperature control system and method for multiple radio frequency ablation needles |
WO2024042964A1 (en) * | 2022-08-23 | 2024-02-29 | 株式会社トップ | High frequency treatment device |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1248059B (en) | 1964-09-01 | 1967-08-24 | Schering Ag | Process for the production of bradykinin-active undeca and dodecapeptides |
US4565200A (en) * | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
US4411266A (en) * | 1980-09-24 | 1983-10-25 | Cosman Eric R | Thermocouple radio frequency lesion electrode |
US4413633A (en) * | 1981-06-01 | 1983-11-08 | Yanda Roman L | Method and apparatus for monitoring body conditions |
US4681122A (en) * | 1985-09-23 | 1987-07-21 | Victory Engineering Corp. | Stereotaxic catheter for microwave thermotherapy |
US4935345A (en) * | 1987-04-07 | 1990-06-19 | Arizona Board Of Regents | Implantable microelectronic biochemical sensor incorporating thin film thermopile |
US4860744A (en) * | 1987-11-02 | 1989-08-29 | Raj K. Anand | Thermoelectrically controlled heat medical catheter |
US4907589A (en) * | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
US5178620A (en) * | 1988-06-10 | 1993-01-12 | Advanced Angioplasty Products, Inc. | Thermal dilatation catheter and method |
US4998933A (en) * | 1988-06-10 | 1991-03-12 | Advanced Angioplasty Products, Inc. | Thermal angioplasty catheter and method |
US4960109A (en) * | 1988-06-21 | 1990-10-02 | Massachusetts Institute Of Technology | Multi-purpose temperature sensing probe for hyperthermia therapy |
US5249585A (en) * | 1988-07-28 | 1993-10-05 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US5191883A (en) * | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
US4966597A (en) * | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
DE3838840C2 (en) * | 1988-11-17 | 1997-02-20 | Leibinger Gmbh | High frequency coagulation device for surgical purposes |
US5057105A (en) * | 1989-08-28 | 1991-10-15 | The University Of Kansas Med Center | Hot tip catheter assembly |
US5254088A (en) | 1990-02-02 | 1993-10-19 | Ep Technologies, Inc. | Catheter steering mechanism |
US5122137A (en) * | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5156151A (en) * | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
JP3091253B2 (en) † | 1991-04-25 | 2000-09-25 | オリンパス光学工業株式会社 | Thermal treatment equipment |
US5383917A (en) † | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5906614A (en) † | 1991-11-08 | 1999-05-25 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using predicted temperature for monitoring and control |
EP0566731A4 (en) * | 1991-11-08 | 1995-02-22 | Ep Technologies | Radiofrequency ablation with phase sensitive power detection. |
US5366443A (en) * | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
US5573533A (en) * | 1992-04-10 | 1996-11-12 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of cardiac tissue |
US5277201A (en) † | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US5391199A (en) * | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
US5496312A (en) * | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
ES2214493T3 (en) † | 1994-06-27 | 2004-09-16 | Boston Scientific Limited | A TISSUE ABLATION REGULATION SYSTEM USING THE TEMPERATURE SENSORS. |
-
1994
- 1994-10-14 ES ES95900364T patent/ES2214493T3/en not_active Expired - Lifetime
- 1994-10-14 EP EP95900364A patent/EP0768841B1/en not_active Revoked
- 1994-10-14 CA CA002194062A patent/CA2194062C/en not_active Expired - Fee Related
- 1994-10-14 AT AT95900364T patent/ATE255369T1/en not_active IP Right Cessation
- 1994-10-14 WO PCT/US1994/011748 patent/WO1996000036A1/en active IP Right Grant
- 1994-10-14 DE DE69433387T patent/DE69433387T2/en not_active Expired - Lifetime
- 1994-10-14 JP JP50309996A patent/JP3564141B2/en not_active Expired - Lifetime
-
1996
- 1996-04-24 US US08/638,989 patent/US5769847A/en not_active Expired - Lifetime
-
2004
- 2004-02-09 JP JP2004032764A patent/JP2004148131A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH10505252A (en) | 1998-05-26 |
EP0768841A1 (en) | 1997-04-23 |
DE69433387T2 (en) | 2004-10-07 |
CA2194062A1 (en) | 1996-01-04 |
ES2214493T3 (en) | 2004-09-16 |
EP0768841A4 (en) | 1998-05-06 |
JP2004148131A (en) | 2004-05-27 |
US5769847A (en) | 1998-06-23 |
WO1996000036A1 (en) | 1996-01-04 |
EP0768841B1 (en) | 2003-12-03 |
ATE255369T1 (en) | 2003-12-15 |
DE69433387D1 (en) | 2004-01-15 |
JP3564141B2 (en) | 2004-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2194062C (en) | System for controlling tissue ablation using temperature sensors | |
CA2194061C (en) | Systems and methods for sensing temperature within the body | |
US5810802A (en) | Systems and methods for controlling tissue ablation using multiple temperature sensing elements | |
US6022346A (en) | Tissue heating and ablation systems and methods using self-heated electrodes | |
CA2174131C (en) | Curvilinear electrode and method for forming lesions | |
US6471699B1 (en) | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements | |
US6652513B2 (en) | Tissue heating and ablation systems and methods which predict maximum tissue temperature | |
US6129724A (en) | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements | |
US6241724B1 (en) | Systems and methods for creating lesions in body tissue using segmented electrode assemblies | |
US5718701A (en) | Ablation electrode | |
US6494880B1 (en) | Systems and methods for controlling power in an electrosurgical probe | |
US6488679B1 (en) | Systems and methods for controlling power in an electrosurgical probe | |
WO1996039967A1 (en) | Tissue heating and ablation systems and methods which predict maximum tissue temperature |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |